Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001405	b-cd8	e6/l (e6/l)	1244	3842	0.00%
3001405	b-t-cd8	e9/l (e6/l)	771	1799	0.00%
3001405	b-t-cd8	— (—)	606	965	100.00%	Distribution not available
3001405	b-t-cd8	e6/l (e6/l)	577	1128	0.00%
3001405	b-cd8	— (—)	125	145	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other diseases of blood and blood-forming organs, wide

432

539

8.33

323.31

3.3

2.5

633.67

498.96

e6/l

0.82

352

449

Diffuse large B-cell lymphoma

198

37.78

315.95

2.4

1.7

490.07

496.18

e6/l

0.03

164

Diffuse large B-cell lymphoma, including Hilmo

198

37.78

315.95

2.4

1.7

490.07

496.18

e6/l

0.03

164

Diffuse large B-cell lymphoma, helper endpoint

198

37.78

315.95

2.4

1.7

490.07

496.18

e6/l

0.03

164

Pneumonia, organism unspecified

961

1629

4.19

314.78

2.5

2.6

601.33

496.16

e6/l

1.82

814

1340

Other bacterial diseases

1049

1695

3.97

309.78

2.9

2.4

556.30

491.76

e6/l

2.73

876

1404

Pneumonias (Asthma/COPD co-morbidities)

1090

1793

4.13

307.65

2.5

2.6

582.17

495.92

e6/l

1.60

917

1474

Bacterial infection, other or unspecified

737

1044

6.08

307.65

2.9

2.4

606.00

494.78

e6/l

1.36

634

879

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1340

1566

6.01

307.65

2.8

2.4

534.42

527.34

e6/l

0.08

1116

1300

Liquid cancers, helper endpoint

933

559

15.24

307.65

3.4

2.0

632.97

450.46

e6/l

3.95

784

478

Non-Hodgkin lymphoma, all, including Hilmo

533

178

32.92

307.65

3.0

1.8

568.68

431.25

e6/l

3.17

445

150

Demyelinating diseases of the central nervous system

369

185

22.01

307.65

4.1

2.0

469.55

598.64

e6/l

1.47

320

149

Influenza and pneumonia

1141

1797

4.09

307.65

2.6

579.47

499.63

e6/l

1.51

965

1476

998

1155

5.30

307.65

2.5

2.4

576.55

486.51

e6/l

1.49

845

958

First line medication for Crohn's disease

1257

1226

5.62

307.65

2.8

2.5

512.58

546.10

e6/l

1.06

1037

1015

Oral corticosteroids

1227

1417

5.21

307.65

2.3

2.7

504.15

545.50

e6/l

1.52

1021

1188

MS-disease / Multiple Sclerosis

351

141

27.89

307.65

4.1

2.1

473.63

630.14

e6/l

1.39

304

115

All pneumoniae

1090

1834

4.02

307.65

2.5

2.6

580.30

504.04

e6/l

1.32

917

1509

Fever of other and unknown origin

823

1014

7.38

307.65

3.0

2.4

601.66

512.03

e6/l

1.13

702

838

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

321

212

15.86

307.65

2.8

2.2

551.86

423.27

e6/l

2.76

268

181

Other bacterial diseases

1032

1631

4.31

307.65

2.9

2.4

596.29

491.17

e6/l

1.95

859

1353

Secondary uncertain malignant neoplasm

327

172

20.09

307.65

2.8

2.0

549.08

433.39

e6/l

2.03

273

147

Immunodeficiencies

334

111

36.37

307.65

2.8

2.4

579.93

582.20

e6/l

0.01

282

Certain disorders involving the immune mechanism

534

469

12.07

307.65

3.0

2.6

531.08

510.76

e6/l

0.26

450

386

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

998

1155

5.30

307.65

2.5

2.4

576.55

486.51

e6/l

1.49

845

958

Immunodeficiency with predominantly antibody defects

256

69.90

307.65

2.7

1.9

556.11

771.38

e6/l

0.49

214

Autoimmune diseases related-to ILD

931

1906

4.23

307.65

2.8

2.4

460.75

567.93

e6/l

4.40

793

1578

ILD medications

1439

1166

6.80

307.65

2.8

2.3

505.00

558.15

e6/l

2.28

1184

964

Non-follicular lymphoma

375

168

24.63

307.65

2.9

2.0

571.72

493.30

e6/l

0.59

310

138

Inflammatory bowel disease treatment related agents

1264

1533

4.67

307.65

2.4

2.7

500.20

545.58

e6/l

1.84

1043

1281

Primary_lymphoid and hematopoietic malignant neoplasms

822

397

22.29

307.65

3.4

2.1

602.02

456.40

e6/l

4.30

694

335

Bacterial infection, other or unspecified

711

952

6.62

307.65

3.0

2.4

615.67

489.48

e6/l

1.56

610

807

Secondary and unspecified malignant neoplasm of lymph nodes

302

117

28.20

307.65

2.8

1.8

555.23

440.27

e6/l

1.52

253

100

ILD medications: immunosuppressive drugs

1031

1019

9.63

307.65

3.0

2.3

472.43

560.92

e6/l

4.17

856

844

Enlarged lymph nodes

364

281

13.53

307.65

2.9

2.4

557.17

498.12

e6/l

1.00

297

236

ILD medications: prednisolone, methylprednisolone, prednisone

1291

1106

6.63

307.65

2.6

2.3

513.23

561.53

e6/l

1.81

1068

917

Non-Hodgkin lymphoma, all

193

49.31

307.65

3.2

1.5

575.22

416.97

e6/l

1.58

155

L04AA Selective immunosuppressants

449

623

7.48

306.55

3.0

2.8

500.73

516.27

e6/l

0.19

360

522

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1041

1852

3.88

305.89

2.5

2.6

586.26

500.59

e6/l

1.48

879

1526

Second line medication for Crohn's disease

726

1588

4.65

304.80

2.5

2.6

433.54

541.22

e6/l

6.49

599

1326

Transplanted organ and tissue status

293

236

13.29

301.79

5.8

2.4

628.43

492.65

e6/l

1.96

254

193

L04AX Other immunosuppressants

701

1532

4.66

294.65

2.5

2.6

438.79

540.23

e6/l

5.52

575

1278

Autoimmune diseases excluding thyroid diseases

1082

1537

3.89

292.60

2.7

2.5

469.10

589.61

e6/l

4.08

924

1250

Autoimmune diseases excluding thyroid diseases, strict definition

1056

1484

3.94

291.29

2.7

2.5

469.38

594.48

e6/l

4.14

902

1208

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

707

1422

4.52

276.75

2.5

572.95

508.51

e6/l

0.62

611

1189

Septicaemia

501

800

5.97

271.83

3.2

2.3

592.49

487.77

e6/l

3.38

404

674

Abnormal findings on diagnostic imaging of lung

538

957

5.49

269.70

2.4

2.3

595.26

507.57

e6/l

0.66

464

812

Other septicaemia

449

713

6.17

254.74

3.3

2.3

587.85

474.19

e6/l

3.67

360

601

Other and unspecified immunodeficiencies with predominantly antibody defects

137

72.10

246.49

2.9

1.3

580.55

712.35

e6/l

0.41

107

Other degenerative diseases of the nervous system

401

403

7.60

245.18

4.0

2.1

460.24

503.80

e6/l

0.94

347

336

Non-invasive ventilation

363

456

7.28

232.52

2.4

3.0

522.98

513.77

e6/l

0.11

331

371

Explicit Sepsis

517

990

4.96

229.54

3.1

2.5

592.98

502.63

e6/l

2.72

417

842

Other demyelinating diseases of the central nervous system

159

26.79

227.18

4.2

2.2

446.51

583.18

e6/l

1.15

134

General symptoms and signs

916

1257

3.68

223.69

2.7

2.4

537.77

509.82

e6/l

0.71

763

1046

ILD medications: azathioprine

240

232

10.67

218.03

2.5

2.1

413.73

524.79

e6/l

2.22

197

196

GASTRO-related operations

670

742

4.57

212.12

2.9

2.2

520.01

539.03

e6/l

0.34

563

567

Any gastric operation

670

742

4.57

212.12

2.9

2.2

520.01

539.03

e6/l

0.34

563

567

Bacterial pneumonia (organism specified)

499

955

4.82

212.06

2.3

2.6

513.16

501.08

e6/l

0.21

414

810

Dental caries

362

572

6.22

206.65

3.2

2.4

548.59

512.51

e6/l

0.55

293

476

Anaemias

344

293

7.83

201.09

3.2

2.4

488.54

535.20

e6/l

0.77

283

238

Kela reimbursement Agammaglobulinemia (D80-84)

109

83.23

199.77

3.6

1.3

519.00

794.43

e6/l

0.73

Nonhereditary hypogammaglobulinemia

112

67.64

199.37

2.7

1.5

534.70

741.29

e6/l

0.59

Rare circulating lymphoid malignancy, including Hilmo

136

27.92

196.47

4.9

2.3

702.53

463.82

e6/l

2.29

106

Bacterial pneumoniae

425

736

5.17

194.19

2.1

2.6

522.60

488.65

e6/l

0.68

347

617

Certain infectious and parasitic diseases

783

1062

3.72

194.12

2.7

2.3

538.85

475.33

e6/l

2.21

641

878

COPD/asthma related infections

820

1155

3.59

193.25

2.6

2.4

537.19

486.51

e6/l

1.55

679

958

COPD/asthma/ILD related infections

820

1155

3.59

193.25

2.6

2.4

537.19

486.51

e6/l

1.55

679

958

Bacterial pneumonia, not elsewhere classified

408

684

5.34

192.93

2.0

2.5

513.82

484.14

e6/l

0.56

331

573

Agranulocytosis

227

243

9.77

192.10

3.6

2.3

561.83

520.02

e6/l

0.34

185

204

Bacterial Sepsis

470

863

4.72

191.54

2.5

2.4

546.80

498.76

e6/l

0.84

392

733

Asthma (only as main-diagnosis)

556

706

4.60

189.34

1.8

2.6

540.68

506.17

e6/l

0.77

459

576

Asthma (only as main-diagnosis), excluding more controls

548

684

4.62

186.66

1.8

2.7

539.59

510.79

e6/l

0.59

451

558

Infections, IBD-co-morbidities

251

179

10.26

185.75

3.3

2.5

712.23

512.95

e6/l

2.77

211

148

Asthma

586

706

4.39

181.23

2.0

2.6

556.94

506.17

e6/l

1.11

481

576

Malignant neoplasm

744

1277

3.48

179.38

3.4

2.2

544.36

510.84

e6/l

0.43

614

1060

Asthma, excluding more controls

574

684

4.41

178.27

2.0

2.7

559.82

510.79

e6/l

1.03

471

558

Follicular lymphoma, hilmo

135

21.64

177.94

3.0

2.1

598.01

609.47

e6/l

0.03

118

Autoimmune diseases

933

1551

3.08

177.46

2.7

2.5

480.69

589.79

e6/l

3.39

792

1261

Caries of dentine

311

509

6.08

174.30

2.9

2.5

553.08

508.42

e6/l

0.66

259

425

Any reimbursement code in KELA

493

501

4.98

170.80

3.0

2.1

542.34

564.90

e6/l

0.31

398

409

Asthma (mode)

564

715

4.26

170.15

2.0

2.6

549.12

504.41

e6/l

0.92

465

583

Azathioprine

240

321

7.70

169.15

2.5

2.7

413.73

520.85

e6/l

2.38

197

275

Viral infections characterized by skin and mucous membrane lesions

487

1238

4.00

168.03

2.6

2.7

554.31

516.13

e6/l

0.82

393

1025

Malignant neoplasm, wide definition for exclusion

744

1332

3.31

165.84

3.4

2.3

545.16

513.74

e6/l

0.41

618

1104

L04AD Calcineurin inhibitors

237

324

7.66

164.50

3.8

2.9

519.95

528.72

e6/l

0.06

191

269

Used for control exclusion in common control thyroid runs

867

1433

3.08

164.32

2.7

2.5

480.78

599.18

e6/l

3.48

728

1166

Medical observation and evaluation for suspected diseases and conditions

528

613

4.44

163.80

3.2

2.1

516.72

508.93

e6/l

0.09

442

484

Implicit bacterial Sepsis

383

735

4.68

156.71

2.5

2.4

547.52

481.57

e6/l

1.12

323

637

Viral Sepsis

257

408

6.44

154.32

2.5

596.52

495.08

e6/l

1.33

207

344

Implicit viral Sepsis

255

407

6.41

152.32

2.5

597.97

495.38

e6/l

1.33

205

343

Implicit bacterial Sepsis

400

790

4.43

151.69

2.4

545.73

490.51

e6/l

0.88

335

677

Other pulmonary diagnosis

562

715

3.97

151.37

2.6

2.7

530.63

507.36

e6/l

0.37

470

584

Excluding asthma or asthma-COPD overlap

561

715

3.96

150.77

2.6

2.7

525.34

507.36

e6/l

0.27

470

584

COPD differential diagnosis

561

715

3.96

150.77

2.6

523.80

504.41

e6/l

0.30

471

583

ILD differential diagnosis

561

715

3.96

150.76

2.6

523.80

504.41

e6/l

0.30

471

583

Lymphoid leukaemia

147

123

12.75

147.89

4.5

2.2

750.66

575.22

e6/l

1.03

122

100

Asthma, unspecified (mode)

388

648

4.55

145.36

2.1

2.7

551.76

499.29

e6/l

0.87

327

531

Bronchitis

864

1994

2.75

145.28

2.8

2.4

551.54

522.51

e6/l

0.57

713

1675

857

1558

2.86

145.19

2.6

2.4

536.11

514.89

e6/l

0.31

706

1302

Systemic connective tissue disorders

370

859

4.38

144.48

2.3

2.4

450.91

521.58

e6/l

1.94

314

716

Any event in cancer register

750

1485

3.00

143.67

3.4

2.3

550.33

487.41

e6/l

2.13

620

1238

Asthma, unspecified (mode), excluding more controls

382

632

4.56

143.27

2.1

2.7

556.19

505.55

e6/l

0.81

321

518

Asthma-related pneumonia

389

947

4.16

142.17

1.8

2.7

590.34

499.31

e6/l

1.97

322

781

Asthma, hospital admissions 3, pneumonia

389

953

4.14

140.96

1.8

2.7

590.34

499.45

e6/l

1.97

322

786

Asthma-related pneumonia or sepsis

389

953

4.14

140.96

1.8

2.7

590.34

499.45

e6/l

1.97

322

786

Optic neuritis

124

15.65

140.32

3.8

2.4

480.55

613.84

e6/l

0.65

105

Other special examinations and investigations of persons without complaint or reported diagnosis

495

613

4.12

140.31

2.7

2.1

536.87

508.93

e6/l

0.41

415

484

ILD, hospital admission 2, with pulmonary infections

143

124

11.90

139.83

2.3

2.0

475.91

425.92

e6/l

0.49

118

105

Acute sinusitis

484

1269

3.57

139.79

2.9

2.4

561.31

499.17

e6/l

1.86

392

1075

Bronchiectasis

148

138

11.20

138.23

1.9

1.8

577.91

496.41

e6/l

0.77

120

114

Other and unspecified types of non-Hodgkin lymphoma, hilmo

118

16.48

137.15

3.1

2.1

625.79

618.68

e6/l

0.02

101

Aplastic and other anaemias

413

1000

3.90

135.60

2.8

2.4

541.51

521.46

e6/l

0.08

336

845

Asthma-related infections

555

1731

3.17

134.93

1.9

2.8

590.62

501.09

e6/l

2.91

456

1430

Asthma, hospital admission 2, infections

555

1731

3.17

134.93

1.9

2.8

590.62

501.09

e6/l

2.91

456

1430

General examination and investigation of persons without complaint and reported diagnosis

475

613

4.08

134.68

3.0

2.1

500.78

508.93

e6/l

0.12

410

484

Other disorders of white blood cells

131

107

12.97

133.65

3.4

2.5

819.17

500.89

e6/l

0.51

103

Implicit viral Sepsis

299

624

4.87

133.26

2.4

585.58

496.72

e6/l

1.34

239

531

Viral infections characterized by skin and mucous membrane lesions

728

2306

2.72

130.32

2.5

2.6

581.63

518.33

e6/l

0.60

594

1925

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

164

103

11.58

129.84

2.2

2.5

475.82

515.22

e6/l

0.33

136

Persons encountering health services for specific procedures and health care

871

2030

2.59

129.08

2.5

2.6

510.89

550.59

e6/l

0.81

720

1687

Zoster [herpes zoster]

225

375

6.14

128.80

2.9

2.4

551.24

509.69

e6/l

0.42

182

318

Acute upper respiratory infections of multiple and unspecified sites

626

1561

3.00

128.72

2.9

2.4

545.21

510.82

e6/l

0.96

511

1310

Disorders of optic nerve and visual pathways

182

244

7.76

128.41

3.6

2.4

476.78

591.08

e6/l

1.51

154

197

Purpura and other haemorrhagic conditions

209

336

6.41

124.31

3.4

2.7

510.46

525.27

e6/l

0.11

162

284

Pneumocystosis

26.58

124.21

3.5

1.8

513.81

682.87

e6/l

0.31

Acute upper respiratory infections

787

1832

2.66

124.19

2.7

2.4

535.07

525.74

e6/l

0.13

643

1538

Oxycodone

344

749

4.21

124.15

2.6

2.5

561.15

507.88

e6/l

0.93

292

642

Pneumonia due to other infectious organisms, not elsewhere classified

19.53

123.81

3.3

2.0

504.65

429.26

e6/l

0.68

Protozoal diseases

101

17.57

120.47

3.4

2.1

507.76

589.66

e6/l

0.23

Other and unspecified anaemias

366

909

3.88

120.46

2.8

2.4

560.28

524.47

e6/l

0.13

292

763

Other anaemias

369

922

3.85

119.90

2.8

2.4

558.63

527.13

e6/l

0.11

295

775

Failure and rejection of transplanted organs and tissues

26.46

119.70

9.2

2.4

563.13

536.48

e6/l

0.08

Examination and observation for other reasons

416

610

3.98

119.55

2.6

2.1

537.20

509.62

e6/l

0.44

338

481

Use of glatiramer acetate

27.05

118.10

4.5

2.6

470.96

456.59

e6/l

0.10

ILD, hospital admissions 3, with pneumonia sepsis

127

119

11.03

118.02

2.3

2.1

469.88

488.22

e6/l

0.13

107

Chronic sinusitis

391

1091

3.62

117.92

2.1

2.7

529.97

490.11

e6/l

0.90

310

913

Other and unspecified disorders of white blood cells

106

14.70

116.06

3.8

2.5

912.99

540.46

e6/l

0.48

Cytomegalovirus infection, IBD co-morbidity

19.13

116.05

4.4

2.1

853.20

439.55

e6/l

3.03

Symptoms and signs involving the skin and subcutaneous tissue

581

2028

2.83

115.51

2.7

2.4

522.74

527.74

e6/l

0.07

484

1695

Asthma and opportunity respiratory infection

106

14.22

114.24

1.5

2.2

623.00

449.03

e6/l

1.94

Cytomegaloviral disease

18.36

113.95

4.4

2.1

853.20

438.74

e6/l

3.00

Implicit fungal Sepsis

118

107

11.48

112.25

2.3

2.2

527.49

435.80

e6/l

1.15

Headache

465

1153

3.25

111.68

2.4

549.16

503.79

e6/l

1.24

396

959

Undetermined asthma, excluding more controls

139

159

8.91

111.26

2.0

2.4

567.74

483.20

e6/l

1.12

117

128

Undetermined asthma

139

159

8.91

111.26

2.0

2.4

567.74

482.47

e6/l

1.12

117

126

Coagulation defects, purpura and other haemorrhagic conditions

251

533

4.82

109.96

3.2

2.6

510.47

511.32

e6/l

0.01

193

444

Implicit Sepsis

554

1464

2.88

106.72

2.3

2.6

539.71

527.88

e6/l

0.12

456

1240

433

1364

3.19

106.37

1.8

2.9

576.79

516.87

e6/l

1.74

352

1114

All influenza

254

565

4.56

104.83

2.7

2.8

601.37

499.13

e6/l

2.42

214

458

Neoplasms

604

1119

2.88

104.67

3.2

2.3

543.48

523.03

e6/l

0.37

483

926

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

15.58

103.42

5.6

2.2

583.62

537.90

e6/l

0.20

Other disorders involving the immune mechanism, not elsewhere classified

14.92

103.33

5.5

2.3

585.71

545.85

e6/l

0.18

Fungal Sepsis

13.90

103.13

2.5

2.1

564.05

414.97

e6/l

1.74

Implicit fungal Sepsis

14.81

101.36

2.6

2.0

513.06

421.07

e6/l

0.99

Use of interferon beta-1a

18.20

100.71

4.3

2.5

404.00

536.58

e6/l

0.93

Mature T/NK-cell lymphomas, hilmo

28.02

100.40

3.5

2.0

562.63

542.46

e6/l

0.06

Other respiratory diseases principally affecting the interstitium

194

360

5.50

99.21

2.1

2.2

482.38

500.86

e6/l

0.16

162

300

Other/unspecified cytomegaloviral diseases

18.07

98.27

4.7

2.0

863.00

483.70

e6/l

2.28

Other acute lower respiratory infections

461

1509

2.94

97.82

2.5

2.7

577.80

519.25

e6/l

1.58

383

1237

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

744

2039

2.39

95.95

3.4

2.3

547.86

525.95

e6/l

0.34

623

1679

Certain infectious and parasitic diseases

483

769

3.17

95.72

2.7

2.3

536.99

462.31

e6/l

1.78

390

633

Mycoses

272

686

4.03

95.32

2.6

536.82

505.42

e6/l

0.43

228

567

Other immunodeficiencies

25.70

95.04

2.5

1.7

601.85

684.09

e6/l

0.23

Other medical care

359

977

3.34

93.07

2.4

2.7

479.25

560.36

e6/l

1.10

295

819

Common variable immunodeficiency

42.87

92.66

2.2

1.2

451.83

802.85

e6/l

0.90

Covid-19 confirmed case

329

967

3.45

91.95

2.3

2.6

595.87

516.21

e6/l

1.63

267

808

Zoster [herpes zoster]

376

1178

3.17

91.85

2.6

2.4

599.12

509.24

e6/l

0.42

313

998

Provisional assignment of new diseases of uncertain etiology

438

1540

2.87

89.82

2.3

2.6

558.41

515.16

e6/l

0.91

349

1283

Codes for special purposes

438

1543

2.86

89.50

2.3

2.6

558.41

514.67

e6/l

0.92

349

1285

Solid cancers, helper endpoint

562

1243

2.69

89.24

2.8

2.2

509.62

512.19

e6/l

0.02

453

1034

Neurological diseases

643

1264

2.57

89.21

3.0

2.3

526.60

532.54

e6/l

0.09

529

1027

Implicit Sepsis

569

1634

2.56

87.48

2.3

2.5

532.57

528.14

e6/l

0.05

468

1378

Selective deficiency of immunoglobulin G [IgG] subclasses

36.34

87.35

2.0

1.8

430.63

733.20

e6/l

0.79

Other interstitial pulmonary diseases

168

310

5.54

86.54

2.2

2.0

464.61

511.78

e6/l

0.45

140

258

Interstitial lung disease

168

310

5.54

86.54

2.2

2.0

464.61

513.11

e6/l

0.46

140

257

Interstitial lung disease endpoints

168

310

5.54

86.54

2.2

2.0

464.61

513.11

e6/l

0.46

140

257

ILD, hospital admissions

167

307

5.56

86.39

2.2

2.0

462.32

516.65

e6/l

0.54

139

255

Asthma (diagnoses ohter than nonallergic)

650

2311

2.35

85.47

1.9

2.7

553.83

526.06

e6/l

0.48

536

1922

Other and unspecified dermatitis

414

1466

2.85

84.12

2.5

2.6

530.95

524.15

e6/l

0.07

338

1216

Dermatitis

469

1765

2.67

84.03

2.5

2.6

533.03

523.28

e6/l

0.12

388

1466

Other systemic involvement of connective tissue (FG)

228

550

4.15

83.05

2.3

2.6

457.96

519.18

e6/l

1.26

189

462

Reimbursement for rheumatic diseases

443

1630

2.73

82.91

2.0

2.7

440.36

544.42

e6/l

2.79

370

1357

Cough

339

1017

3.19

82.63

2.7

2.8

527.02

513.50

e6/l

0.19

282

829

Thrombocytopenia, unspecified

117

157

7.72

82.53

3.9

2.2

566.97

522.93

e6/l

0.22

129

Abnormalities of breathing

648

1586

2.39

80.92

2.2

2.7

537.38

523.31

e6/l

0.25

537

1304

Herpesviral [herpes simplex] infections

150

270

5.69

79.48

2.5

2.7

528.03

525.74

e6/l

0.02

120

229

Sarcoidosis

152

278

5.59

79.12

2.4

2.5

392.96

523.22

e6/l

1.79

134

228

Diagnoses used for exclusion with ILD

232

599

3.93

78.74

2.2

2.6

407.15

518.01

e6/l

2.75

199

507

Other diseases of pleura

325

899

3.20

78.31

2.4

2.5

486.90

522.94

e6/l

0.56

268

761

Other systemic involvement of connective tissue

244

658

3.76

77.82

2.3

2.5

457.36

528.10

e6/l

1.53

204

547

Viral pneumonia

143

251

5.81

77.73

2.5

2.6

497.12

485.87

e6/l

0.11

112

196

Complications of medical and surgical care

520

1967

2.45

76.66

3.2

2.3

531.54

523.21

e6/l

0.11

442

1644

Multiple myeloma, including Hilmo

15.02

76.17

3.5

1.4

630.72

413.44

e6/l

1.54

Diseases of the respiratory system

388

623

3.14

76.11

2.4

2.5

539.22

498.32

e6/l

0.55

315

512

Malaise and fatigue

316

796

3.22

75.32

2.0

2.4

516.54

512.16

e6/l

0.04

256

668

Explicit bacterial Sepsis

124

197

6.43

74.60

2.8

2.7

579.89

496.08

e6/l

0.86

103

169

Persons encountering health services for examination and investigation

379

613

3.12

73.62

2.8

2.1

512.95

508.93

e6/l

0.04

305

484

Oedema, not elsewhere classified

213

536

3.96

73.14

2.5

2.3

465.69

485.92

e6/l

0.26

168

458

Other disorders of lacrimal gland

290

913

3.21

72.68

3.1

2.4

481.74

514.28

e6/l

0.56

261

751

Asthma, hospital admissions , main diagnosis only

593

2334

2.26

72.05

1.8

2.7

550.73

526.65

e6/l

0.44

489

1942

Dyspnoea

613

2031

2.24

70.84

2.3

2.6

515.04

532.43

e6/l

0.28

516

1692

Streptococcal septicaemia

101

137

7.55

70.41

3.0

2.6

584.52

456.19

e6/l

1.41

114

Diseases of the skin and subcutaneous tissue

662

1476

2.26

70.34

2.6

537.23

544.94

e6/l

0.08

541

1233

Encephalitis

12.81

69.89

3.1

2.1

518.89

453.19

e6/l

0.35

Other encephalitis

13.42

69.71

3.1

2.1

516.12

491.16

e6/l

0.10

Condition for Implicit Sepsis (Organ dysfunction codes)

559

1704

2.33

69.71

2.3

2.5

535.01

522.75

e6/l

0.14

456

1439

Other bacterial intestinal infections

170

382

4.52

69.51

2.9

2.7

622.38

493.76

e6/l

1.78

141

321

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

127

222

5.87

69.50

6.6

2.3

570.19

550.83

e6/l

0.12

114

191

Dermatitis and eczema

753

2254

2.08

69.34

2.5

2.6

535.17

532.75

e6/l

0.03

630

1875

Renal failure

318

944

3.00

69.19

2.5

532.47

519.02

e6/l

0.13

278

793

Acute bronchitis

331

1133

2.89

68.87

2.5

2.7

572.44

515.05

e6/l

1.23

279

919

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

223

255

4.41

68.59

2.9

2.1

559.51

573.92

e6/l

0.09

185

202

Enterocolitis due to Clostridium difficile

120

201

6.10

68.52

3.0

2.3

644.43

515.49

e6/l

1.02

172

Allergic asthma (mode)

173

389

4.39

68.19

1.8

2.8

537.09

490.12

e6/l

0.59

139

302

Intestinal infectious diseases

661

2362

2.14

68.11

2.5

577.20

523.37

e6/l

1.14

538

1975

Allergic asthma (mode), excluding more controls

173

390

4.38

67.95

1.8

2.7

537.09

498.15

e6/l

0.46

139

304

Polyarthropathies

496

1330

2.45

67.84

2.3

2.7

507.22

510.48

e6/l

0.04

410

1112

SLE (Finngen)

15.36

66.79

2.7

3.2

395.69

697.35

e6/l

0.65

ILD, hospital admissions 1, main diag only

142

287

5.05

66.13

2.1

2.0

451.82

530.49

e6/l

0.85

119

237

Other viral diseases

352

1292

2.73

65.95

3.2

2.7

635.36

512.92

e6/l

2.68

290

1049

Chronic lower respiratory diseases

811

2154

2.01

65.91

2.1

2.7

562.18

527.22

e6/l

0.69

662

1796

Renal tubulo-interstitial diseases

592

2014

2.20

65.58

2.5

2.6

534.93

523.52

e6/l

0.14

500

1672

Disorders of lacrimal system

321

1133

2.85

65.45

3.0

2.4

486.55

546.94

e6/l

0.79

285

925

Neurological diseases, wide definition

255

341

3.79

65.22

3.1

2.2

545.82

550.40

e6/l

0.03

202

260

Inflammatory diseases of the central nervous system

116

199

5.99

64.77

2.5

2.7

520.74

564.02

e6/l

0.30

170

Gastrointestinal diseases

419

777

2.72

64.68

2.7

2.6

544.86

509.31

e6/l

0.53

339

633

Other viral diseases

299

1025

2.95

64.40

3.5

2.7

656.96

513.99

e6/l

2.79

250

825

Heart failure, not strict

488

1394

2.39

64.03

2.4

2.6

485.50

550.25

e6/l

1.01

409

1178

Bacterial intestinal infections, IBD co-morbidities

169

404

4.25

63.84

2.9

2.6

623.14

456.09

e6/l

2.76

140

337

Hodgkin lymphoma, hilmo

11.83

63.57

2.3

2.5

477.65

638.34

e6/l

0.46

Diseases of the eye and adnexa

582

1281

2.29

63.56

3.0

2.5

515.73

542.86

e6/l

0.54

490

1054

Candidiasis

252

792

3.22

63.45

2.5

582.99

513.20

e6/l

1.31

205

651

Human immunodeficiency virus [HIV] disease

13.21

63.23

4.7

2.4

964.48

746.12

e6/l

0.56

Herpesviral [herpes simplex] infections

224

657

3.45

63.07

2.4

2.8

544.57

509.69

e6/l

0.55

178

546

All kidney diseases

666

2201

2.08

62.65

2.5

2.6

527.13

533.70

e6/l

0.08

558

1826

Complications of surgical and medical care, not elsewhere classified

645

2130

2.08

61.17

3.1

2.4

528.41

529.95

e6/l

0.02

548

1774

Candidiasis

148

332

4.54

60.79

2.4

560.85

515.43

e6/l

0.40

123

276

Other disorders of skin and subcutaneous tissue, not elsewhere classified

141

306

4.69

60.30

2.6

2.4

583.25

478.18

e6/l

0.86

126

257

Other necrotizing vasculopathies

128

7.23

60.25

2.3

2.1

462.04

537.35

e6/l

0.39

110

Hernia of abdominal wall, postoperative

106

178

6.01

60.22

2.3

2.1

903.62

510.62

e6/l

0.63

144

Opioids

619

1493

2.16

60.08

2.5

538.16

511.48

e6/l

0.56

512

1249

Condition for Implicit Sepsis (Organ dysfunction codes)

568

1813

2.17

59.85

2.3

2.5

545.50

522.36

e6/l

0.31

456

1532

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

405

1662

2.42

59.39

3.5

2.3

530.80

528.51

e6/l

0.02

350

1385

Osteopathies and chondropathies

389

1476

2.47

58.98

2.7

2.6

512.48

538.11

e6/l

0.31

325

1226

Other necrotizing vasculopathies (FG)

100

8.13

58.53

2.4

2.1

484.14

438.65

e6/l

0.30

Pain, not elsewhere classified

192

536

3.62

58.23

2.2

2.5

528.45

502.15

e6/l

0.33

163

451

Early onset COPD, excluding more controls

122

242

5.09

57.85

1.7

2.5

591.12

475.48

e6/l

1.71

100

209

Visual disturbances and blindness

375

1529

2.47

57.57

2.7

2.6

493.18

516.85

e6/l

0.50

320

1266

ILD-related respiratory insufficiency

11.64

57.44

2.1

2.3

394.13

641.41

e6/l

0.81

Drug-induced neutropenia

149

6.49

56.88

3.7

2.0

561.13

496.35

e6/l

0.36

128

Symptoms and signs involving the circulatory and respiratory systems

656

1591

2.08

56.83

2.5

2.7

532.37

523.33

e6/l

0.15

552

1309

Tramadol

482

1292

2.30

56.82

2.1

2.5

545.08

511.44

e6/l

0.72

399

1087

Chronic kidney disease

211

626

3.34

56.26

2.5

2.4

521.23

510.87

e6/l

0.07

184

520

Acute renal failure

167

436

3.88

55.95

2.6

2.3

519.93

488.87

e6/l

0.29

148

362

Diseases of oesophagus, stomach and duodenum

684

2064

1.99

55.63

2.1

2.7

516.89

536.68

e6/l

0.30

586

1705

Care involving use of rehabilitation procedures

424

1694

2.32

55.52

2.3

2.6

488.45

544.22

e6/l

1.07

335

1402

Infections of the skin and subcutaneous tissue

427

1867

2.28

54.68

2.6

2.7

510.55

531.64

e6/l

0.40

354

1541

Procreative management

305

944

2.72

54.68

2.4

2.8

565.46

527.18

e6/l

0.63

246

769

Diarrhoea and gastroenteritis of presumed infectious origin

487

2028

2.18

54.64

2.4

2.6

579.37

510.85

e6/l

1.57

396

1688

Multiple myeloma and malignant plasma cell neoplasms

8.39

54.50

3.5

2.1

645.27

550.90

e6/l

0.33

Nutritional anaemias

328

1262

2.52

52.38

2.4

2.5

447.78

518.00

e6/l

2.03

279

1050

Other reaction to severe stress, and adjustment disorders

293

1113

2.66

52.29

3.4

2.6

565.81

521.94

e6/l

0.86

254

918

Unspecified acute lower respiratory infection

151

388

3.95

51.85

2.5

2.7

649.60

523.29

e6/l

1.53

124

320

All chronic kidney diseases

369

1258

2.42

51.80

2.4

2.6

519.68

512.34

e6/l

0.08

320

1033

Malignant neoplasm of eye, brain and central nervous system

9.41

51.51

2.0

2.2

497.87

484.07

e6/l

0.06

Finngen Rheumatological endpoints

616

1744

2.02

51.42

2.3

2.7

511.01

528.21

e6/l

0.32

509

1461

Visual disturbances

344

1427

2.43

51.01

2.7

2.5

486.28

515.75

e6/l

0.65

291

1179

Systemic lupus erythematosus

9.89

50.66

2.7

2.5

395.69

452.12

e6/l

0.34

Other diseases of intestines

693

2057

1.92

50.64

2.4

2.7

535.14

519.33

e6/l

0.30

563

1709

Other and unspecified aplastic anaemias

18.81

50.33

2.2

1.8

408.97

467.05

e6/l

0.23

Other disorders of skin and subcutaneous tissue

435

1766

2.20

50.21

2.3

2.5

519.18

523.56

e6/l

0.04

358

1484

Other bacterial intestinal infections

185

558

3.35

49.94

3.0

2.6

617.21

497.08

e6/l

1.83

153

466

Idiopathic thrombocytopenic purpura

9.53

49.89

3.1

2.2

575.18

603.26

e6/l

0.06

Erysipelas

370

1195

2.37

49.45

2.1

2.4

513.50

491.46

e6/l

0.36

303

1004

Parasetamol

482

1106

2.22

49.45

2.6

515.21

507.86

e6/l

0.10

388

924

Chronic rhinitis, nasopharyngitis and pharyngitis

243

866

2.83

49.10

1.9

2.8

572.95

480.72

e6/l

1.33

203

711

Asthma/COPD (KELA code 203)

610

2145

1.96

49.03

2.0

2.7

541.57

527.00

e6/l

0.23

496

1790

Dialysis, with operation codes

130

313

4.23

48.85

2.9

2.8

524.82

514.12

e6/l

0.05

109

258

Abnormal findings on diagnostic imaging of central nervous system

108

7.08

48.50

2.8

542.24

605.30

e6/l

0.26

Erysipelas

288

991

2.59

47.65

2.2

2.4

515.87

495.79

e6/l

0.27

236

844

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

10.67

47.43

3.2

1.6

768.37

425.91

e6/l

1.20

Other skin changes

149

404

3.74

47.39

2.7

2.4

572.33

517.49

e6/l

0.52

123

342

Nausea and vomiting

214

710

2.98

47.27

2.8

2.6

516.79

530.44

e6/l

0.14

176

581

Disorders of eyelid, lacrimal system and orbit

533

2022

2.01

47.20

2.8

2.5

494.18

535.66

e6/l

0.87

473

1679

Disturbances of skin sensation

218

753

2.93

46.74

2.6

473.65

526.39

e6/l

1.00

182

628

Polyneuropathies and other disorders of the peripheral nervous system

169

503

3.40

46.65

3.4

2.5

569.19

493.73

e6/l

0.92

143

423

Asthma and allergy

107

225

4.75

46.61

1.6

3.0

558.67

506.81

e6/l

0.44

171

Asthma and allergy, excluding more controls

107

226

4.73

46.36

1.6

3.0

558.67

511.03

e6/l

0.40

172

Iron deficiency anaemia

285

1115

2.54

46.33

2.4

2.5

447.66

521.80

e6/l

1.91

241

928

Symptoms and signs involving the nervous and musculoskeletal systems

386

1753

2.22

46.30

2.9

2.6

562.76

506.19

e6/l

1.46

328

1451

Osteoporosis

173

487

3.35

46.00

2.8

2.2

492.99

521.33

e6/l

0.24

145

400

Codeine

542

1457

2.03

45.51

2.3

2.5

518.86

511.02

e6/l

0.12

451

1221

Other diseases of upper respiratory tract

653

1796

1.90

45.23

2.5

2.7

563.64

524.98

e6/l

0.65

551

1480

Pain in joint

376

1046

2.30

44.96

2.2

2.5

507.02

530.06

e6/l

0.38

328

858

Cardiovascular diseases

459

1153

2.15

44.56

2.6

2.9

519.09

532.34

e6/l

0.18

373

955

Urticaria and erythema

289

1181

2.47

44.40

2.4

2.8

523.41

514.93

e6/l

0.12

228

971

Other specified/unspecified systemic involvement of connective tissue

106

6.78

44.27

2.0

2.4

423.27

541.89

e6/l

0.61

Other diseases of the respiratory system

153

443

3.49

44.10

2.3

2.6

503.47

501.06

e6/l

0.02

118

366

Other respiratory disorders and diseases

153

443

3.49

44.10

2.3

2.6

503.47

501.06

e6/l

0.02

118

366

Gastro-oesophageal reflux disease

421

1726

2.12

43.83

2.3

2.7

567.09

530.67

e6/l

0.47

376

1426

Factors influencing health status and contact with health services

156

194

4.06

43.79

2.9

2.1

599.85

500.75

e6/l

0.73

134

163

Asthma, including avohilmo

732

2292

1.80

43.60

2.0

2.7

553.34

530.04

e6/l

0.40

602

1915

Any death

365

1156

2.28

43.59

2.5

596.58

514.14

e6/l

0.37

309

986

Malignant neoplasm of brain

9.77

43.51

1.9

2.1

466.83

533.98

e6/l

0.30

Intestinal infectious diseases

703

2219

1.82

43.28

2.5

562.05

521.08

e6/l

0.78

576

1859

Respiratory insufficiency

7.85

42.81

1.8

2.2

579.08

464.65

e6/l

0.76

Symptoms and signs involving the urinary system

469

1769

2.03

42.69

3.0

2.5

529.45

540.87

e6/l

0.12

400

1483

Nephropathy related operations

124

319

3.96

42.65

2.8

2.7

511.55

505.19

e6/l

0.03

103

263

Haemorrhage from respiratory passages

208

658

2.87

42.29

2.5

679.23

490.51

e6/l

0.52

170

548

Malignant neoplasm of brain, including Hilmo

7.23

41.63

2.0

2.4

465.06

490.97

e6/l

0.13

Diarrhoea and gastroenteritis of presumed infectious origin

617

2215

1.84

41.15

2.4

2.5

566.57

520.86

e6/l

0.87

506

1856

Non-allergic asthma (mode), excluding more controls

112

271

4.13

41.06

1.5

2.4

541.12

502.38

e6/l

0.38

211

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

317

1355

2.29

40.94

2.0

2.7

570.98

500.82

e6/l

1.16

269

1131

FESS (DNB20)

118

302

3.97

40.87

2.3

2.6

506.41

543.80

e6/l

0.31

259

Symptoms and signs concerning food and fluid intake

168

5.12

40.60

2.3

2.1

546.59

496.43

e6/l

0.35

140

Ethmoidectomy

121

317

3.88

40.55

2.2

2.8

508.95

539.25

e6/l

0.25

271

Other problems related to primary support group, including family circumstances

149

435

3.40

40.54

3.8

2.5

556.35

543.36

e6/l

0.10

119

350

Methotrexate

101

231

4.42

40.54

1.9

2.8

491.75

531.48

e6/l

0.30

197

6-mercaptopurine

7.76

40.50

3.6

2.7

367.54

533.76

e6/l

1.87

Non-allergic asthma (mode)

112

274

4.08

40.47

1.5

2.4

541.12

492.31

e6/l

0.52

214

Other and unspecified iron deficiency

229

877

2.63

40.29

2.4

2.5

462.35

514.18

e6/l

0.92

194

730

Cardiovascular diseases (excluding rheumatic etc)

467

1328

2.03

40.02

2.5

2.9

514.63

526.38

e6/l

0.16

378

1099

Special screening examination for infectious and parasitic diseases

153

329

3.45

39.89

2.3

601.94

501.71

e6/l

2.01

129

260

11.89

39.82

1.5

2.5

686.54

535.94

e6/l

0.78

Rheumatoid arthritis

206

669

2.78

39.51

2.1

2.5

417.20

499.66

e6/l

1.91

171

561

Continuous positive airway pressure

147

367

3.41

39.07

2.5

2.9

589.29

537.20

e6/l

0.33

131

291

Budesonide

106

259

4.14

39.06

2.1

2.7

427.26

530.50

e6/l

1.43

224

Viral infections of the central nervous system

179

4.91

38.88

2.5

569.47

568.95

e6/l

0.00

154

Viral pneumonia (known virus, not influenza)

8.72

38.87

3.3

2.4

597.45

464.84

e6/l

0.86

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

216

529

2.78

38.69

2.2

2.0

492.66

506.56

e6/l

0.07

174

448

Recurrent aphthous stomatitis , including avohilmo

131

376

3.54

38.40

3.7

2.4

475.55

524.03

e6/l

0.53

110

307

Seropositive rheumatoid arthritis

161

522

3.10

38.37

2.1

2.5

400.77

526.69

e6/l

3.34

133

440

Viral infections of the central nervous system

164

5.05

37.84

2.5

2.4

558.51

572.55

e6/l

0.07

141

Noninfective enteritis and colitis

327

1508

2.18

37.82

2.4

2.8

506.78

524.71

e6/l

0.27

280

1239

Stomatitis and related lesions

170

577

2.98

37.78

3.5

2.5

452.24

513.12

e6/l

1.05

139

472

Mixed connective tissue disease

128

5.68

37.74

2.0

2.4

410.53

572.53

e6/l

1.14

106

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

143

5.34

37.47

2.6

1.9

558.91

484.40

e6/l

0.39

122

Acute lymphocytic leukaemia, including Hilmo

14.92

37.29

8.1

1.9

667.00

515.81

e6/l

0.57

Acute lymphocytic leukaemia

14.92

37.29

8.1

1.9

667.00

515.81

e6/l

0.57

Acute lymphocytic leukaemia, helper endpoint

14.92

37.29

8.1

1.9

667.00

515.81

e6/l

0.57

Mycoses

519

2445

1.85

37.26

2.5

531.89

532.48

e6/l

0.01

431

2051

Haemolytic anaemias

7.31

37.06

3.9

2.5

571.24

563.08

e6/l

0.03

Other malignant neoplasms of skin (=non-melanoma skin cancer)

199

484

2.83

36.95

2.2

1.9

483.53

506.00

e6/l

0.10

159

413

Disorders of other endocrine glands

306

1370

2.21

36.61

2.8

2.6

530.40

523.10

e6/l

0.09

258

1126

Gout

164

481

3.02

36.42

2.8

2.5

600.07

518.11

e6/l

0.60

137

411

Gout, FINNGEN

164

555

2.97

36.37

2.8

2.2

600.07

496.04

e6/l

0.84

137

474

Abnormal findings on examination of blood, without diagnosis

291

1189

2.26

36.28

2.4

2.6

543.35

514.37

e6/l

0.41

231

1013

Anxiety disorders, excluding more controls

501

1736

1.89

35.82

2.9

2.5

529.64

529.14

e6/l

0.01

430

1444

COPD (mode)

129

288

3.54

35.75

1.8

2.3

523.93

498.16

e6/l

0.23

109

246

Molar incisor enamel hypoplasia, with caries

8.41

35.63

5.9

2.5

445.19

574.25

e6/l

0.83

Sulfasalazine

158

537

2.96

34.97

2.2

2.9

482.84

544.08

e6/l

0.80

127

460

Pulmonary heart disease, diseases of pulmonary circulation

191

719

2.68

34.89

2.4

716.93

509.18

e6/l

0.54

161

601

Other symptoms and signs involving the nervous and musculoskeletal systems

275

1225

2.26

34.81

3.1

2.6

588.90

515.31

e6/l

1.61

236

1017

Persons encountering health services in other circumstances, wide

685

2052

1.72

34.72

2.5

2.6

526.89

535.85

e6/l

0.13

578

1704

Pain in throat and chest

471

1483

1.91

34.66

2.4

2.6

506.79

519.75

e6/l

0.23

382

1222

Symptoms and signs involving the digestive system and abdomen

596

1666

1.80

34.60

2.7

2.6

515.16

527.44

e6/l

0.23

478

1381

Malignant neoplasm of skin

217

573

2.61

34.54

2.2

2.0

490.82

505.73

e6/l

0.08

175

485

Neurotic, stress-related and somatoform disorders

545

2125

1.80

34.31

2.9

2.5

539.75

526.53

e6/l

0.20

469

1759

Other and unspecified polyneuropathies, also in other diseases

134

420

3.23

34.17

3.1

2.4

588.17

475.44

e6/l

1.38

113

351

Other specified/unspecified arthritis

182

677

2.71

34.08

2.1

2.7

703.32

511.61

e6/l

0.46

152

560

Neuromuscular dysfunction of bladder

196

4.41

33.90

3.3

2.3

467.19

511.71

e6/l

0.38

162

L01XX Other antineoplastic agents

6.43

33.84

3.2

1.8

1375.18

567.00

e6/l

0.59

Other arthritis (FG)

198

774

2.58

33.56

2.1

2.8

686.55

522.73

e6/l

0.41

165

652

Other noninfective gastroenteritis and colitis

194

752

2.60

33.45

2.5

2.7

558.47

508.66

e6/l

0.63

161

606

Low back pain

444

1682

1.90

33.41

2.4

2.5

501.77

546.69

e6/l

0.80

369

1398

Vocal cord dysfunction

227

3.95

33.29

1.8

3.6

530.80

568.89

e6/l

0.31

197

Other specific joint derangements/joint disorders

456

1565

1.89

32.91

2.3

2.7

518.70

518.62

e6/l

0.00

395

1300

Hypoplasia of dental enamel

6.84

32.85

5.3

3.1

381.76

547.16

e6/l

1.60

Codeine or tramadol medication

633

2011

1.73

32.85

2.3

2.5

522.05

537.26

e6/l

0.22

531

1696

Urticaria

229

968

2.39

32.84

2.4

2.9

536.43

522.59

e6/l

0.18

185

792

Anxiety disorders

545

2146

1.78

32.77

2.8

2.5

538.94

530.37

e6/l

0.12

469

1776

Depression medications

178

302

2.98

32.61

2.7

2.3

526.52

498.89

e6/l

0.31

143

245

Other/unspecified rheumatoid arthritis

232

4.02

32.57

1.9

2.1

403.09

486.12

e6/l

0.77

196

Localized swelling, mass and lump of skin and subcutaneous tissue

206

834

2.49

32.47

2.8

2.5

509.19

515.84

e6/l

0.07

176

693

Hypothyroidism (congenital or acquired)

157

285

3.13

32.44

2.4

2.3

518.22

510.84

e6/l

0.06

127

231

Other functional intestinal disorders

282

1209

2.18

32.20

2.6

2.7

546.96

514.33

e6/l

0.47

227

1001

Adrenocortical insufficiency

6.63

32.13

1.8

2.4

551.50

457.61

e6/l

0.56

Persons encountering health services for other counselling and medical advice, not elsewhere classified

642

2050

1.71

31.92

2.5

2.6

530.52

535.89

e6/l

0.07

537

1703

COPD, hospital admissions 3, with asthma pneumonia sepsis

159

479

2.86

31.79

1.7

2.3

566.94

519.49

e6/l

0.50

136

405

Hypothyroidism and >3 levothyroxin purchases

155

284

3.10

31.63

2.4

2.3

523.29

508.84

e6/l

0.13

125

230

Hypothyroidism, levothyroxine purchases

155

284

3.10

31.63

2.4

2.3

523.29

508.84

e6/l

0.13

125

230

Abdominal and pelvic pain

582

1666

1.76

31.58

2.8

2.6

523.54

527.44

e6/l

0.06

478

1381

Migraine

325

1284

2.06

31.52

2.4

2.6

597.59

508.10

e6/l

0.38

282

1056

Nonsuppurative otitis media

194

665

2.55

31.10

2.8

2.6

570.40

527.66

e6/l

0.60

161

535

Other soft tissue disorders, not elsewhere classified

559

1880

1.75

30.78

2.4

2.6

532.48

550.84

e6/l

0.26

468

1541

Osteoporosis with pathological fracture (FG)

6.03

30.76

2.3

1.8

465.49

493.21

e6/l

0.12

Dysphagia

151

539

2.82

30.65

2.0

2.4

468.62

513.38

e6/l

0.60

121

455

Other disorders of optic [2nd] nerve and visual pathways

162

4.61

30.65

3.5

2.5

479.66

617.16

e6/l

1.07

130

Respiratory disorders in diseases classified elsewhere

11.72

30.51

2.4

2.0

403.78

534.21

e6/l

0.69

Other viral diseases, not elsewhere classified

167

629

2.68

30.47

3.3

2.6

656.31

506.05

e6/l

1.51

141

508

Care involving dialysis

179

4.38

30.45

2.7

2.9

556.34

510.57

e6/l

0.16

148

Follow-up examination after treatment for conditions other than malignant neoplasms

193

493

2.60

30.38

2.8

2.1

566.99

503.52

e6/l

0.92

163

393

Rheumatoid arthritis, including avohilmo

225

983

2.30

29.93

2.0

2.4

424.81

532.35

e6/l

3.01

183

822

Syncope and collapse

204

720

2.44

29.91

2.3

2.4

540.21

508.97

e6/l

0.38

159

612

Other disorders of fluid, electrolyte and acid-base balance

183

691

2.54

29.87

1.9

2.6

688.05

498.03

e6/l

0.46

154

583

Convulsions, not elsewhere classified

140

480

2.90

29.81

2.7

2.6

546.17

509.64

e6/l

0.43

111

399

Acute tubulo-interstitial nephritis

348

1539

1.96

29.67

2.4

2.6

549.00

535.18

e6/l

0.14

286

1279

Pulmonary heart disease

169

651

2.61

29.57

2.5

2.4

768.62

512.62

e6/l

0.61

143

546

Complications of procedures, not elsewhere classified

443

2029

1.81

29.57

2.2

2.4

523.73

529.18

e6/l

0.07

377

1694

Pulmonary embolism

169

652

2.61

29.48

2.5

2.4

768.62

511.69

e6/l

0.62

143

547

Other viral diseases, not elsewhere classified

216

930

2.33

29.38

2.9

2.8

638.41

509.19

e6/l

1.67

178

749

Diseases of the ear and mastoid process

665

2016

1.66

29.38

2.3

2.6

530.61

530.00

e6/l

0.01

554

1672

L01XE Protein kinase inhibitors

106

5.51

29.37

5.1

2.0

1224.27

537.11

e6/l

0.55

Acute suppurative otitis media

216

868

2.34

29.37

2.9

2.7

572.17

536.10

e6/l

0.57

184

705

Idiopathic pulmonary fibrosis

128

5.00

29.34

1.7

2.1

442.19

536.04

e6/l

0.47

112

Sicca syndrome [Sjögren]

157

4.53

28.96

2.5

2.3

397.05

520.99

e6/l

1.07

131

All influenza (not pneumonia)

108

330

3.31

28.78

2.9

2.8

624.87

493.45

e6/l

2.10

262

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

221

966

2.28

28.56

3.4

2.5

580.15

519.67

e6/l

0.89

173

785

Subjective visual disturbances

166

646

2.59

28.52

2.6

501.52

530.32

e6/l

0.33

143

531

COPD, hospital admission 2, with asthma infections

175

590

2.56

28.42

1.7

2.4

560.79

506.29

e6/l

0.69

148

497

Venous thromboembolism

283

1333

2.06

28.35

2.4

655.42

503.55

e6/l

0.57

231

1138

Other disorders of urethra and urinary system

393

1522

1.87

28.25

2.4

534.32

495.45

e6/l

0.60

327

1283

Chronic diseases of tonsils and adenoids

457

1611

1.80

28.23

2.7

2.8

527.94

531.88

e6/l

0.04

392

1328

Pneumonia derived septicemia

6.00

28.03

2.5

2.8

664.34

487.46

e6/l

1.02

Human immunodeficiency virus [HIV] disease resulting in other conditions

8.47

28.00

3.5

2.4

980.28

793.49

e6/l

0.39

Diseases of the musculoskeletal system and connective tissue

354

898

1.99

27.71

2.6

559.56

537.87

e6/l

0.25

284

712

Molar incisor enamel hypoplasia

203

4.02

27.60

4.5

2.8

419.12

584.84

e6/l

2.17

154

Pain (limb, back, neck, head abdominally)

420

1133

1.86

27.42

2.8

2.5

517.23

522.63

e6/l

0.07

346

923

Other heart diseases

317

1036

2.01

27.36

2.5

3.0

460.24

520.88

e6/l

1.48

262

859

Disorders of sclera, cornea, iris and ciliary body

322

1671

1.94

27.26

2.7

2.6

519.85

510.93

e6/l

0.13

281

1382

Noninfectious colitis NAS

107

339

3.19

26.93

2.8

561.49

531.15

e6/l

0.19

280

Seropositive rheumatoid arthritis, wide

161

635

2.56

26.93

2.1

2.4

400.77

523.15

e6/l

3.01

133

532

Other/unspecified seropositive rheumatoid arthritis

159

624

2.57

26.87

2.1

2.4

401.34

524.93

e6/l

2.98

131

522

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

158

619

2.57

26.80

2.1

2.4

396.30

525.50

e6/l

3.22

130

518

Other symptoms and signs involving the digestive system and abdomen

113

371

3.07

26.75

3.2

2.7

538.16

548.66

e6/l

0.07

100

314

DVT of lower extremities and pulmonary embolism

219

989

2.22

26.66

2.5

713.20

507.41

e6/l

0.64

183

841

Pneumococcal septicemia

6.06

26.64

2.6

2.9

665.35

593.83

e6/l

0.19

Pain in limb

471

1814

1.74

26.50

2.5

2.6

531.44

552.30

e6/l

0.29

390

1489

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

199

3.93

26.46

2.6

2.3

516.37

499.60

e6/l

0.08

169

Obesity related asthma

207

922

2.26

26.39

1.8

2.8

629.84

498.75

e6/l

1.72

176

778

Polyuria

140

521

2.71

26.35

3.4

2.4

568.71

498.94

e6/l

0.47

126

438

Cellulitis

156

614

2.56

26.24

2.8

2.6

536.34

519.21

e6/l

0.15

137

510

Episodal and paroxysmal disorders

630

1971

1.63

26.15

2.5

2.7

544.05

521.70

e6/l

0.44

529

1613

Dorsalgia

554

1770

1.68

26.13

2.4

2.5

525.62

545.33

e6/l

0.29

467

1469

Lower back pain or/and sciatica

573

2278

1.65

26.11

2.4

2.5

514.94

534.57

e6/l

0.35

485

1910

Heart failure,strict

259

870

2.11

26.02

2.3

2.5

447.13

560.40

e6/l

1.52

216

733

Chronic laryngitis and laryngotracheitis

287

3.35

25.84

1.7

2.7

543.37

476.40

e6/l

0.89

244

Mood disorders, excluding more controls

513

1809

1.70

25.71

2.7

2.5

526.48

527.52

e6/l

0.01

431

1511

Metabolic disorders

527

1917

1.68

25.66

2.4

2.7

560.83

504.46

e6/l

1.29

433

1608

Other heart diseases, wide

542

1997

1.67

25.38

2.4

2.7

479.88

558.25

e6/l

2.16

439

1667

Glomerular diseases

128

465

2.78

25.28

1.9

2.8

581.17

492.09

e6/l

0.59

113

383

Irritable bowel syndrome

171

715

2.41

25.26

2.2

2.7

523.28

510.92

e6/l

0.14

144

591

Diseases of middle ear and mastoid

362

1622

1.83

25.08

2.6

562.84

523.59

e6/l

0.94

310

1328

Conjunctivitis (acute, non atopic)

204

922

2.22

24.92

2.5

2.7

488.46

536.98

e6/l

0.85

178

742

Drug-induced adrenocortical insufficiency

7.81

24.83

1.7

2.0

491.96

515.84

e6/l

0.08

Dermatitis due to substances taken internally

119

4.80

24.82

3.0

2.5

597.42

460.67

e6/l

1.12

100

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

312

1656

1.89

24.62

2.2

2.5

508.28

510.47

e6/l

0.03

267

1378

Suppurative and unspecified otitis media

252

1096

2.05

24.56

2.8

2.7

574.42

518.67

e6/l

1.20

217

891

5-aminosalicylic acid

126

462

2.75

24.42

2.0

3.0

496.92

536.03

e6/l

0.39

106

391

Other (seronegative) rheumatoid arthritis, wide

119

427

2.81

24.07

2.0

2.5

417.41

520.61

e6/l

1.50

359

Hypoplasia of dental enamel , including avohilmo

195

3.84

23.84

4.8

2.8

395.43

590.19

e6/l

2.87

148

Depression

533

2216

1.63

23.79

2.7

2.5

533.43

529.82

e6/l

0.05

447

1856

Postprocedural disorders of nervous system

188

3.84

23.64

2.7

2.6

488.36

576.11

e6/l

0.70

155

Chronic ulcer of skin, not elsewhere classified

128

4.52

23.60

2.0

1.9

479.60

471.80

e6/l

0.04

108

Other and unspecified tonsillitis

208

808

2.18

23.48

2.7

2.6

570.15

531.82

e6/l

0.52

185

665

Later onset COPD, excluding more controls

148

3.88

23.42

1.8

2.0

436.32

504.34

e6/l

0.56

127

Generalized skin eruption due to drugs and medicaments

5.30

23.24

3.1

2.8

612.46

605.05

e6/l

0.02

Extracorporeal dialysis

147

4.23

23.13

3.0

2.4

584.61

520.22

e6/l

0.18

125

Lung cancer and mesothelioma

162

3.83

23.08

2.0

2.1

446.48

524.31

e6/l

0.68

137

Cutaneous abscess, furuncle and carbuncle

176

777

2.28

23.02

2.0

2.8

494.68

528.15

e6/l

0.38

138

646

Pleural effusion

278

3.23

22.97

2.5

2.2

486.45

516.37

e6/l

0.17

237

Disorders of ocular muscles, binocular movement, accommodation and refraction

299

1590

1.87

22.96

3.1

2.6

482.35

530.88

e6/l

1.26

246

1295

Disorders of conjunctiva

476

2318

1.65

22.95

2.4

2.6

483.28

541.77

e6/l

1.59

398

1919

Other complications of surgical and medical care, not elsewhere classified

225

3.51

22.88

2.4

2.3

504.97

540.82

e6/l

0.20

190

Basal cell carcinoma

163

466

2.43

22.77

2.2

2.0

493.54

508.15

e6/l

0.06

131

402

Iridocyclitis

148

610

2.45

22.65

2.2

2.7

533.02

515.92

e6/l

0.16

130

504

Other neurological diseases

369

1645

1.77

22.65

2.5

496.96

534.08

e6/l

0.55

317

1370

Lack of expected normal physiological development

5.68

22.65

4.3

2.0

624.29

599.06

e6/l

0.11

Mood disorders

558

2265

1.60

22.59

2.6

2.5

535.33

527.67

e6/l

0.11

467

1899

Other and unspecified urticaria

147

605

2.45

22.59

2.2

2.9

537.55

520.84

e6/l

0.17

123

497

Acute generalized exanthematous pustulosis

101

4.96

22.56

3.4

2.7

610.37

583.42

e6/l

0.09

Nerve, nerve root and plexus disorders

552

2115

1.60

22.37

2.5

513.66

536.71

e6/l

0.40

468

1770

Mood [affective] disorders

556

2265

1.60

22.34

2.6

2.5

535.78

527.98

e6/l

0.12

465

1899

Childhood asthma (age<16)

211

3.31

22.24

2.1

3.0

554.03

488.97

e6/l

0.65

152

Childhood asthma (age<16), excluding more controls

211

3.31

22.23

2.1

3.0

554.03

490.74

e6/l

0.63

152

Functional dyspepsia

154

655

2.37

21.97

2.1

2.6

505.65

510.91

e6/l

0.05

129

548

Meningitis

104

4.80

21.78

1.8

2.5

524.93

586.06

e6/l

0.24

Other diseases of pericardium

5.74

21.68

2.1

458.28

615.05

e6/l

0.45

Vasomotor and allergic rhinitis

226

1104

2.02

21.65

2.0

2.8

529.36

493.90

e6/l

0.56

191

897

Other disorders of adrenal gland

121

4.48

21.59

1.8

2.6

559.34

497.15

e6/l

0.34

Acute pharyngitis

112

411

2.73

21.38

2.4

2.6

626.18

524.59

e6/l

1.02

327

Diplopia

292

3.08

21.22

3.0

2.6

480.94

537.22

e6/l

0.54

248

COPD

208

817

2.09

21.19

1.7

2.5

523.45

499.93

e6/l

0.29

176

693

Disorders of thyroid, IBD co-morbidities

190

3.27

21.16

2.4

2.2

520.28

515.01

e6/l

0.03

156

Glomerular disorders in diseases classified elsewhere

268

3.17

21.01

1.9

2.7

509.11

487.31

e6/l

0.14

225

Other diseases of urinary system

546

1938

1.59

20.94

2.9

2.4

522.62

506.63

e6/l

0.26

448

1629

Malignant neoplasm, without specification of site, including Hilmo

6.90

20.80

2.9

1.8

507.54

429.05

e6/l

0.42

Other infectious diseases

159

3.89

20.79

3.3

2.2

536.73

541.35

e6/l

0.02

136

Viral warts

260

3.20

20.74

2.5

2.8

549.90

550.94

e6/l

0.01

216

Epilepsy

195

933

2.10

20.72

2.3

2.8

698.15

514.45

e6/l

0.45

157

764

Symptoms and signs involving speech and voice

186

879

2.13

20.60

1.8

2.5

489.29

515.74

e6/l

0.38

154

733

Other disorders of eye and adnexa

104

379

2.77

20.53

3.0

2.4

526.74

524.22

e6/l

0.01

303

Other chronic obstructive pulmonary disease

199

785

2.10

20.53

1.7

2.5

533.41

496.82

e6/l

0.49

169

665

Exclusions for E4_PCOS_BROAD

140

591

2.39

20.38

2.5

2.8

526.33

505.53

e6/l

0.19

111

485

Myalgia

145

624

2.34

20.19

2.0

2.7

491.23

528.38

e6/l

0.51

126

516

Myeloproliferative diseases

154

3.88

20.08

4.1

2.0

1187.94

543.58

e6/l

0.51

131

Secondary hypertension

170

3.71

20.01

1.9

3.0

578.73

523.90

e6/l

0.15

138

Chronic gastritis

134

559

2.41

20.00

2.4

541.98

513.00

e6/l

0.24

118

467

Other and unspecified drugs and medicaments

192

3.54

19.91

2.5

2.6

513.05

545.05

e6/l

0.16

163

Use of hypnotics and sedatives

560

2071

1.56

19.85

2.4

2.5

516.98

535.83

e6/l

0.30

452

1749

Other diseases of lip and oral mucosa

226

1168

1.95

19.57

2.4

2.6

539.56

511.37

e6/l

0.35

197

969

Abnormal findings on diagnostic imaging of other body structures

270

3.07

19.45

2.9

2.3

416.17

563.16

e6/l

1.70

224

Ocular pain

200

3.45

19.44

3.2

2.9

440.13

515.81

e6/l

0.96

161

Soft tissue disorders

574

1914

1.55

19.43

2.6

530.50

550.81

e6/l

0.28

487

1567

Other dorsopathies, not elsewhere classified

535

1787

1.57

19.37

2.4

2.5

529.11

545.57

e6/l

0.24

453

1484

Otitis media, unspecified

102

347

2.74

19.30

2.8

2.6

618.44

551.23

e6/l

0.61

273

Bleeding

424

1849

1.64

19.30

2.5

2.6

569.16

524.12

e6/l

0.21

350

1549

Conjunctivitis

427

2207

1.62

19.26

2.5

2.6

489.86

541.36

e6/l

1.21

359

1822

Other intervertebral disc disorders

419

1530

1.65

19.24

2.4

2.5

529.88

550.13

e6/l

0.25

364

1276

Diaphragmatic hernia

178

851

2.10

19.15

2.2

2.4

519.92

499.07

e6/l

0.23

154

720

Diseases of the myoneural junction and muscle

273

3.04

19.11

2.9

2.7

489.61

524.31

e6/l

0.23

228

350

2.77

18.96

2.4

2.7

483.21

500.68

e6/l

0.15

290

Disorders of lens

328

1169

1.76

18.92

2.5

2.6

516.81

507.23

e6/l

0.10

279

995

Dermatopolymyositis

8.40

18.90

2.1

1.9

364.17

485.57

e6/l

0.61

Inflammatory bowel disease

199

997

2.01

18.88

2.2

2.8

459.87

527.97

e6/l

1.34

172

819

Osteonecrosis

117

4.25

18.84

2.9

2.1

584.63

602.16

e6/l

0.05

100

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

251

834

1.91

18.84

2.6

2.9

524.12

502.81

e6/l

0.25

207

709

Eosinophilia

7.95

18.82

1.7

1.9

363.74

441.04

e6/l

0.46

Hypothyroidism, strict autoimmune

303

1117

1.79

18.80

2.3

2.4

515.35

591.99

e6/l

1.03

254

922

Any mental disorder

580

1899

1.53

18.71

2.8

2.5

525.89

530.59

e6/l

0.05

477

1573

Basal cell carcinoma, including avohilmo

160

495

2.23

18.63

2.2

2.0

474.88

504.19

e6/l

0.14

129

423

Biological medication for rheuma

129

548

2.38

18.59

1.8

2.8

515.01

521.72

e6/l

0.05

102

457

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

105

4.40

18.58

2.0

1.5

544.85

368.29

e6/l

1.52

Arthropathies

511

1649

1.57

18.56

2.4

2.7

533.51

523.10

e6/l

0.15

431

1359

Ulcerative colitis, NAS

103

396

2.63

18.36

2.2

2.6

486.66

515.74

e6/l

0.24

326

Cerebrovascular diseases (FINNGEN)

171

564

2.16

18.33

2.3

3.1

557.14

497.98

e6/l

0.76

140

485

Chronic iridocyclitis

4.60

18.24

2.3

2.2

476.68

612.84

e6/l

0.57

Hypokalaemia

239

3.13

18.18

1.8

2.7

515.58

524.35

e6/l

0.05

199

COPD-related respiratory insufficiency

219

3.23

18.13

1.7

2.0

491.79

525.03

e6/l

0.19

186

Viral meningitis

4.98

18.10

3.0

2.4

523.47

508.97

e6/l

0.07

Benign neoplasm: Colon

249

1299

1.84

18.04

2.4

492.46

534.24

e6/l

0.36

213

1106

Persons encountering health services in other circumstances

222

1167

1.90

18.01

2.3

2.7

551.31

510.80

e6/l

0.62

199

959

Antihypertensive medication - note that there are other indications

386

1228

1.67

18.00

2.4

2.8

550.99

557.22

e6/l

0.05

319

1009

Heart failure, strict

263

1015

1.83

17.96

2.3

2.4

446.60

557.75

e6/l

1.71

220

856

Heart failure and antihypertensive medication

142

401

2.33

17.92

2.6

2.8

438.47

585.11

e6/l

0.85

114

338

Other infectious diseases

196

3.36

17.89

3.2

2.3

543.13

540.43

e6/l

0.01

166

Suggestive for eosinophilic asthma

201

3.32

17.88

1.9

2.7

581.42

502.33

e6/l

0.56

173

Crohn disease

367

2.67

17.87

2.2

2.7

447.34

528.23

e6/l

0.82

296

Benign neoplasm of colon, rectum, anus and anal canal

290

1442

1.75

17.68

2.3

2.5

500.86

531.46

e6/l

0.28

247

1235

Collagenous colitis

198

3.32

17.61

2.1

2.5

598.17

531.50

e6/l

0.34

168

Seronegative rheumatoid arthritis

213

3.22

17.58

2.2

2.6

415.00

525.89

e6/l

1.15

180

Other and unspecified diseases of blood and blood-forming organs

6.67

17.54

2.0

2.2

691.52

522.06

e6/l

0.60

All-cause Heart Failure

257

994

1.83

17.49

2.3

2.4

444.79

558.68

e6/l

1.74

215

841

Disorders of mineral metabolism

181

3.41

17.23

2.3

2.6

510.19

502.05

e6/l

0.04

150

Congenital malformations, deformations and chromosomal abnormalities

341

1967

1.66

17.18

2.5

2.6

535.42

528.91

e6/l

0.09

286

1623

Viral pneumonia (unknown virus, not influenza)

172

3.48

17.15

2.4

481.18

528.14

e6/l

0.36

146

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

158

751

2.11

17.13

2.1

2.6

554.89

511.41

e6/l

0.58

122

622

Genitourinary diseases

345

1018

1.71

17.09

3.2

2.5

550.01

526.22

e6/l

0.28

284

821

Non-ischemic cardiomyopathy

153

572

2.16

17.08

2.5

497.44

526.49

e6/l

0.29

124

478

Tonsillectomy and adenotomy

357

1506

1.66

17.04

2.7

583.83

525.13

e6/l

1.70

304

1217

Iron deficiency anaemia secondary to blood loss (chronic)

336

2.70

17.02

1.9

2.4

387.90

503.81

e6/l

1.53

277

Malignant neoplasm of respiratory system and intrathoracic organs

206

3.04

16.95

2.3

1.8

472.39

446.55

e6/l

0.21

176

Misadventures to patients during surgical and medical care

309

2.77

16.93

2.3

2.2

457.87

486.45

e6/l

0.18

257

Other headache syndromes

220

1184

1.86

16.86

2.4

2.7

528.26

500.63

e6/l

0.44

182

973

Diseases of liver

188

962

1.96

16.85

2.1

2.7

539.32

515.00

e6/l

0.23

154

809

Anterior Iridocyclitis

124

541

2.31

16.84

2.2

2.6

524.55

524.59

e6/l

0.00

110

450

Disorders of calcium metabolism

132

3.84

16.81

2.3

2.4

521.69

487.86

e6/l

0.16

111

All anxiety disorders

343

1642

1.66

16.78

2.6

560.43

511.44

e6/l

1.20

291

1358

Postprocedural endocrine and metabolic disorders, not elsewhere classified

312

2.75

16.64

3.0

2.6

583.01

504.00

e6/l

0.84

260

Exfoliative dermatitis

15.13

16.56

3.0

2.1

414.29

331.85

e6/l

0.39

Other metabolic disorders

353

2.63

16.52

3.3

2.7

572.15

511.84

e6/l

0.60

292

Missing teeth due to accident, extraction or parodontitis

279

1525

1.73

16.51

2.7

2.4

540.46

530.01

e6/l

0.10

238

1294

Spondylopathies

375

1378

1.63

16.39

2.1

2.5

497.56

551.25

e6/l

0.82

314

1151

Somatoform disorder

102

413

2.49

16.38

1.8

2.8

535.83

516.43

e6/l

0.12

349

Erythema multiforme

6.45

16.36

2.1

2.4

484.90

567.19

e6/l

0.27

Voice disturbances

149

709

2.11

16.34

1.9

2.6

498.11

515.77

e6/l

0.20

122

589

Early onset COPD

122

537

2.29

16.24

1.7

2.7

591.12

523.09

e6/l

0.78

100

453

Atopic dermatitis

326

1614

1.66

16.24

2.4

2.7

534.13

514.22

e6/l

0.34

272

1329

Congenital malformations, deformations and chromosomal abnormalities

361

2075

1.61

16.12

2.5

2.6

537.08

526.29

e6/l

0.17

302

1719

Malignant neoplasm of other connective and soft tissue, including Hilmo

5.33

16.11

1.8

1.6

481.28

419.88

e6/l

0.28

Constipation

456

2056

1.54

16.09

2.2

2.6

482.78

539.87

e6/l

1.25

360

1728

169

774

2.01

15.98

2.4

2.2

523.43

547.72

e6/l

0.12

138

657

Speech and linguistic disorders, excluding more controls

262

2.84

15.92

3.7

2.7

535.94

509.38

e6/l

0.16

199

Other symptoms and signs involving the circulatory and respiratory systems

129

3.76

15.74

1.8

2.8

406.05

480.29

e6/l

0.70

103

Benign neoplasms

518

1903

1.50

15.74

2.4

2.6

510.21

530.18

e6/l

0.35

428

1584

Other joint disorders

471

1619

1.54

15.72

2.5

2.7

513.55

522.22

e6/l

0.16

406

1341

Dorsopathies

538

1833

1.50

15.63

2.5

531.72

544.45

e6/l

0.15

451

1513

Mental and behavioural disorders due to tobacco

203

3.14

15.62

2.5

2.7

585.80

534.01

e6/l

0.34

177

Smoking dependency

204

3.13

15.49

2.5

2.7

585.80

541.55

e6/l

0.27

179

Depression or dysthymia

356

1206

1.63

15.46

2.7

2.5

533.82

536.13

e6/l

0.02

296

1015

Other antidepressants

523

1791

1.50

15.43

2.3

2.5

524.09

534.49

e6/l

0.14

422

1523

Suppurative and necrotic conditions of lower respiratory tract

113

3.95

15.40

1.7

2.4

490.65

566.75

e6/l

0.30

Abnormal weight loss

221

3.02

15.33

1.8

2.5

525.05

531.03

e6/l

0.03

182

Etanercept

175

3.31

15.32

1.7

2.9

493.57

566.71

e6/l

0.33

146

Other specified and unspecified retinal disorders

5.10

15.30

2.8

2.3

469.36

645.71

e6/l

0.60

Unspecified kidney failure

180

3.25

15.28

2.3

2.2

425.38

498.16

e6/l

0.49

149

Vascular disorders of the intestines

4.28

15.24

1.4

1.9

384.06

467.60

e6/l

0.55

Tumor necrosis factor alpha inhibitors

110

477

2.33

15.22

1.8

2.7

482.85

530.68

e6/l

0.40

394

COPD, early/later onset

199

897

1.88

15.20

1.7

2.4

533.41

513.79

e6/l

0.22

169

764

COPD, hospital admissions

198

894

1.88

15.20

1.7

2.4

534.45

513.91

e6/l

0.23

168

762

Hypertensive diseases (excluding secondary)

287

975

1.72

15.14

2.0

2.9

546.69

513.16

e6/l

0.34

237

816

Viral warts

134

633

2.13

15.04

2.6

2.7

549.52

507.49

e6/l

0.42

114

528

Diseases of the digestive system

230

1297

1.77

14.98

2.6

504.74

513.29

e6/l

0.09

200

1076

Weight loss

247

2.87

14.82

2.3

2.6

546.14

523.62

e6/l

0.11

205

Endocrine, nutritional and metabolic diseases

459

1525

1.53

14.78

2.5

2.7

553.29

516.42

e6/l

0.66

372

1257

Cerebral palsy and other paralytic syndromes

292

2.70

14.76

2.6

2.8

474.71

565.00

e6/l

0.91

241

Symptoms and signs involving cognition, perception, emotional state and behaviour

489

2248

1.49

14.67

2.2

2.6

559.72

522.66

e6/l

0.59

410

1882

Temporomandibular joint disorders, including avohilmo

243

1388

1.73

14.64

2.0

2.6

558.41

507.76

e6/l

1.00

210

1150

Fissure and fistula of anal and rectal regions

128

602

2.14

14.53

2.4

2.7

473.52

517.13

e6/l

0.45

104

503

Migraine without aura

129

610

2.13

14.45

2.4

2.8

487.00

492.71

e6/l

0.06

106

496

Secondary thrombocytopenia

10.97

14.42

2.7

2.1

545.43

507.52

e6/l

0.09

Other disorders of ear

464

2032

1.50

14.41

2.4

2.6

522.83

527.14

e6/l

0.05

404

1675

Spondyloarthritis

372

2.46

14.35

1.6

2.2

476.58

561.21

e6/l

0.81

302

Persons encountering health services in circumstances related to reproduction

331

1385

1.62

14.35

2.8

2.9

570.39

511.85

e6/l

1.36

277

1144

Rheumatism, unspecified

280

2.70

14.26

1.6

2.5

465.03

493.88

e6/l

0.27

235

Systemic sclerosis (FG)

6.29

14.25

1.5

2.7

353.47

391.88

e6/l

0.17

Disorders of skin appendages

262

1561

1.68

14.24

2.4

2.7

598.85

506.91

e6/l

1.34

216

1294

Acute and subacute iridocyclitis

112

504

2.24

14.22

2.2

2.7

529.51

517.72

e6/l

0.09

100

417

Deviated nasal septum

161

830

1.95

14.16

2.2

2.7

564.24

514.10

e6/l

0.37

143

702

Anxiety (asthma-related co-morbidities)

331

1606

1.60

14.14

2.7

2.6

559.77

507.39

e6/l

1.29

282

1345

Recurrent or chronic depression

220

866

1.79

14.09

2.8

2.6

551.40

499.53

e6/l

0.91

183

725

Biological medicines for asthma

5.98

14.07

1.2

2.2

507.89

553.06

e6/l

0.16

Other disorders of bone

118

545

2.18

14.06

2.8

2.7

556.88

513.74

e6/l

0.41

102

453

Disorders of parathyroid gland

414

2.35

13.98

2.3

2.4

442.55

520.05

e6/l

0.76

345

Diverticular disease of intestine

302

1175

1.65

13.97

2.1

2.6

557.42

502.84

e6/l

0.71

261

994

Other/unspecified dorsalgia

186

1003

1.85

13.91

2.6

507.56

516.04

e6/l

0.08

161

832

Systemic sclerosis

6.14

13.91

1.5

2.4

353.47

488.18

e6/l

0.76

Viral and other specified intestinal infections

141

683

2.03

13.85

2.8

575.36

525.39

e6/l

0.56

120

558

Acute lymphadenitis

151

3.36

13.83

2.8

2.9

535.26

565.75

e6/l

0.14

129

Abnormal results of function studies

197

3.03

13.81

2.4

2.8

558.76

561.78

e6/l

0.01

163

Malignant neoplasm of bronchus and lung, including Hilmo

211

2.79

13.67

2.0

1.7

449.42

428.04

e6/l

0.15

178

Myocarditis

4.01

13.61

2.3

3.1

501.85

513.02

e6/l

0.05

Diseases of arteries, arterioles and capillaries (FINNGEN)

120

380

2.20

13.55

2.0

3.1

485.97

485.67

e6/l

0.00

330

Fibromyalgia

210

2.93

13.53

1.4

2.6

482.42

533.43

e6/l

0.51

174

Skin changes due to chronic exposure to nonionizing radiation

152

719

1.96

13.45

2.5

2.0

506.38

551.59

e6/l

0.22

125

609

Fentanyl

149

3.31

13.34

2.6

2.5

514.90

492.59

e6/l

0.12

122

Need for other prophylactic measures

155

3.27

13.29

3.5

2.9

1542.45

579.44

e6/l

0.47

131

Disorders of psychological development

108

455

2.22

13.28

3.3

2.7

518.51

550.68

e6/l

0.26

353

Migraine with aura

140

705

2.00

13.26

2.0

2.7

748.78

498.41

e6/l

0.50

125

574

Other CVD (FINNGEN)

155

3.02

13.21

1.8

2.7

513.67

481.52

e6/l

0.18

132

Pruritus

235

2.79

13.19

2.1

2.3

505.76

497.18

e6/l

0.06

192

Hypo-osmolality and hyponatraemia

361

2.41

13.16

2.0

2.7

918.28

510.20

e6/l

0.45

304

Pain associated with micturition

270

2.65

13.07

3.5

2.3

529.41

497.20

e6/l

0.30

227

Simple and mucopurulent chronic bronchitis

4.13

13.04

1.9

2.5

798.59

465.97

e6/l

2.02

Other anxiety disorders

251

1309

1.67

12.95

2.5

2.6

583.00

511.01

e6/l

1.62

211

1083

Systemic sclerosis, icd10

5.71

12.94

1.5

2.2

353.47

487.49

e6/l

0.78

Other diseases of intestine

289

2.58

12.91

2.6

2.7

483.43

496.62

e6/l

0.09

245

Fitting and adjustment of other devices

142

651

1.98

12.90

2.3

2.5

504.60

507.12

e6/l

0.01

133

549

Other gastritis (incl. Duodenitis)

106

486

2.19

12.89

2.0

2.6

449.21

508.64

e6/l

0.88

406

Rash and other nonspecific skin eruption

227

2.80

12.88

3.1

2.4

584.20

510.46

e6/l

0.41

191

Retention of urine

151

640

1.94

12.85

2.3

2.4

524.50

499.69

e6/l

0.24

121

553

Atopic dermatitis, strict definition with reimbursement

182

975

1.81

12.78

2.4

2.8

510.70

520.74

e6/l

0.12

149

788

Abnormalities of heart beat

157

817

1.89

12.70

2.2

2.7

493.58

501.56

e6/l

0.08

130

673

Bronchitis, not specified as acute or chronic

180

3.03

12.69

2.5

2.6

647.15

508.57

e6/l

0.92

142

Lumbar disc prolapse

300

1448

1.59

12.68

2.4

2.5

549.60

554.29

e6/l

0.04

266

1214

Intracranial trauma

255

1079

1.67

12.68

2.4

2.3

551.32

531.01

e6/l

0.25

207

873

Actinic keratosis

146

699

1.94

12.66

2.5

2.0

448.55

552.37

e6/l

0.93

119

591

Disorders of oesophagus in diseases classified elsewhere

9.53

12.55

1.7

2.3

520.58

565.59

e6/l

0.12

Kidney transplant status

161

3.16

12.52

2.1

3.0

610.11

490.47

e6/l

0.31

132

Hypothyroidism, drug reimbursement

163

2.83

12.49

2.4

2.3

420.89

467.88

e6/l

0.48

137

Other chronic obstructive pulmonary disease, including avohilmo

230

1127

1.69

12.47

1.7

2.5

514.08

510.65

e6/l

0.04

197

956

Dentofacial anomalies [including malocclusion]

368

1959

1.51

12.45

2.3

2.6

520.17

513.35

e6/l

0.11

315

1616

Faecal incontinence

131

3.39

12.44

2.9

2.3

393.97

520.55

e6/l

0.79

109

Sciatica+with lumbago

240

1333

1.66

12.37

2.3

2.6

535.46

549.24

e6/l

0.14

208

1122

Deforming dorsopathies

145

759

1.92

12.32

2.0

2.7

461.79

527.59

e6/l

0.92

127

637

Pneumothorax

147

3.23

12.32

2.3

547.00

564.59

e6/l

0.07

129

Adalimumab

267

2.61

12.31

1.9

2.9

509.98

565.72

e6/l

0.33

225

Sequelae of external causes of morbidity and mortality

133

677

1.98

12.27

2.8

2.4

616.66

508.75

e6/l

1.46

105

565

Allergic rhinitis

196

1114

1.75

12.27

2.1

2.9

539.32

532.22

e6/l

0.08

165

897

Disorders of tooth development and eruption

356

2.24

12.08

2.7

2.6

544.08

500.48

e6/l

0.44

299

Other pulmonary heart/vessel disease

4.16

12.06

2.4

2.1

448.65

487.45

e6/l

0.17

Triptan medication for migraine, min. 3 purchases

297

1441

1.58

12.06

2.2

2.6

495.87

514.69

e6/l

0.39

253

1195

Benzodiazepine use

488

2358

1.43

12.03

2.5

551.51

528.16

e6/l

0.39

404

1981

Lung diseases due to external agents

282

2.53

11.99

1.8

2.3

442.14

528.21

e6/l

0.71

240

Gastric ulcer

318

2.43

11.96

1.7

2.4

473.10

491.27

e6/l

0.10

265

Diseases of salivary glands

163

895

1.83

11.95

2.2

2.5

478.06

503.76

e6/l

0.34

130

748

Combined immunodeficiencies

11.02

11.91

3.7

1.8

566.29

599.00

e6/l

0.06

Other diseases of blood and blood-forming organs

130

3.34

11.91

2.0

2.3

631.79

568.85

e6/l

0.22

112

Hypermobility syndrome

121

3.43

11.80

1.7

2.9

530.76

525.17

e6/l

0.03

100

Other pleural conditions

172

2.99

11.77

2.6

2.1

387.37

550.99

e6/l

1.41

146

Dizziness and giddiness

358

1893

1.50

11.76

2.3

2.6

571.17

520.71

e6/l

0.69

308

1590

COPD related to multimorbidity

161

741

1.84

11.74

1.7

2.4

510.37

511.60

e6/l

0.01

137

626

Carrier of infectious disease

4.68

11.70

1.9

2.1

2201.45

476.06

e6/l

0.56

IBD patients in KELA-register

137

717

1.92

11.69

2.0

2.7

440.01

521.25

e6/l

1.33

120

587

Secondary right heart disease

4.51

11.68

2.6

2.1

484.78

507.35

e6/l

0.08

Tuberculosis, IBD comorbidity

112

3.51

11.68

1.7

1.9

698.09

427.45

e6/l

1.16

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

453

2016

1.44

11.66

2.4

2.5

512.76

520.28

e6/l

0.11

375

1703

Personal history of malignant neoplasm

122

3.40

11.64

2.4

2.2

552.31

446.25

e6/l

0.95

Diseases of arteries, arterioles and capillaries

286

1341

1.58

11.63

1.9

2.5

466.83

546.26

e6/l

1.26

232

1146

Gastroduodenal ulcer

106

506

2.10

11.58

1.6

2.4

470.69

519.86

e6/l

0.42

426

Chronic hepatitis, not elsewhere classified

4.34

11.51

1.1

2.0

566.35

574.25

e6/l

0.02

Viral and other specified intestinal infections

167

901

1.80

11.48

2.7

2.8

578.51

526.18

e6/l

0.68

140

733

Ulcerative enterocolitis

4.58

11.45

1.8

2.3

517.19

488.79

e6/l

0.11

Other and unspecified visual disturbances

219

2.72

11.44

2.5

482.73

540.20

e6/l

0.43

186

Psychiatric diseases

499

1759

1.42

11.43

2.7

2.5

524.83

529.53

e6/l

0.05

410

1461

Diseases of oral cavity, salivary glands and jaws

263

830

1.63

11.42

2.3

545.98

564.27

e6/l

0.11

212

692

Covid-19 suspected case

128

661

1.95

11.37

2.4

2.7

499.60

523.27

e6/l

0.20

552

Keratitis

181

1041

1.75

11.37

3.1

2.6

529.20

531.15

e6/l

0.02

158

860

Senile cataract

262

995

1.62

11.37

2.3

2.6

515.62

497.83

e6/l

0.16

225

848

Allergic urticaria

220

2.71

11.36

2.6

3.1

603.80

565.16

e6/l

0.21

187

Polymyalgia rheumatica

220

2.70

11.33

2.0

485.13

487.55

e6/l

0.01

183

Paralytic ileus and intestinal obstruction

113

559

2.03

11.31

2.1

2.6

535.39

506.55

e6/l

0.24

468

Inflammatory diseases of female pelvic organs

286

1345

1.57

11.27

2.2

2.4

512.62

525.60

e6/l

0.14

241

1118

Migraine, single triptan purchase ok & required. ICD-code if available is included

392

1811

1.47

11.26

2.5

2.6

516.70

515.43

e6/l

0.02

335

1504

Triptan medication for migraine, single purchase ok

392

1811

1.47

11.26

2.5

2.6

516.70

515.43

e6/l

0.02

335

1504

Abnormality of white blood cells, not elsewhere classified

9.11

11.24

5.0

1.8

625.19

498.00

e6/l

0.34

Abnormal involuntary movements

322

2.38

11.21

2.1

2.5

465.00

499.12

e6/l

0.33

270

Other inflammation of eyelid

310

2.40

11.19

2.9

2.4

460.95

520.47

e6/l

0.50

259

Dental operations

273

874

1.61

11.15

2.6

2.2

525.29

525.46

e6/l

0.00

226

707

Ulcerative colitis

138

736

1.88

11.14

2.1

2.8

492.34

510.23

e6/l

0.18

116

611

Hypercalcemia

3.91

11.13

2.3

2.2

485.08

569.83

e6/l

0.24

Osteomyelitis

141

3.16

11.12

2.0

2.1

570.82

551.83

e6/l

0.07

120

Disorders of synovium and tendon

254

1399

1.59

11.09

2.5

2.6

541.81

548.44

e6/l

0.05

222

1162

Gout, idiopatic and unspecified

105

510

2.07

11.08

2.8

2.4

515.92

495.31

e6/l

0.15

439

Heart failure and bmi 25plus

154

563

1.85

11.03

2.4

2.6

425.14

537.94

e6/l

2.47

125

490

Neuralgia and neuritis, unspecified

107

3.50

11.00

1.6

2.7

600.24

534.76

e6/l

0.25

Non-small cell lung cancer, including Hilmo

157

2.95

10.99

1.9

1.6

432.81

411.15

e6/l

0.15

135

Papulosquamous disorders

188

1106

1.71

10.91

2.2

2.6

481.75

518.32

e6/l

0.40

155

934

Migraine with aura and triptan purchases

467

2.11

10.90

2.0

2.7

497.76

512.37

e6/l

0.16

377

Disorders of choroid and retina

358

1719

1.48

10.89

2.2

2.6

475.70

543.56

e6/l

1.36

303

1444

Raynaud syndrome

208

2.72

10.88

1.4

2.4

362.09

545.44

e6/l

2.09

176

Other congenital malformations

333

2.34

10.88

3.7

3.0

560.66

565.63

e6/l

0.03

260

Other disorders of nervous system

138

3.15

10.84

1.9

2.4

530.22

568.07

e6/l

0.14

120

Hernia

443

2089

1.42

10.80

2.6

616.43

514.92

e6/l

0.65

382

1730

Infections with a predominantly sexual mode of transmission

169

967

1.75

10.78

2.4

2.6

640.51

512.90

e6/l

2.86

144

792

Concussion

215

1064

1.65

10.76

2.5

2.3

569.26

531.38

e6/l

0.50

175

859

Seropositive rheumatoid arthritis, strict definition

347

2.29

10.75

2.5

376.60

539.82

e6/l

2.66

293

Speech and linguistic disorders

382

2.21

10.70

4.0

2.7

569.69

544.29

e6/l

0.16

293

Ulcer of lower limb, not elsewhere classified

268

2.48

10.69

2.2

416.69

457.04

e6/l

0.26

229

Inflammatory bowel disease, strict (require KELA)

137

740

1.86

10.66

2.0

2.7

440.01

526.57

e6/l

1.48

120

607

Vasculitis limited to skin, not elsewhere classified

5.09

10.55

2.7

1.7

420.12

485.97

e6/l

0.27

Malignant neoplasm of endocrine gland

110

3.39

10.54

3.4

2.2

484.93

448.33

e6/l

0.19

Other or unspecified ileus, impaction or obstruction

356

2.26

10.54

1.7

2.6

519.14

524.93

e6/l

0.03

302

L04AC Interleukin inhibitors

146

3.05

10.51

1.6

2.9

629.78

577.98

e6/l

0.19

126

Myeloproliferative diseases (CML excluded)

146

3.04

10.50

4.1

2.1

1449.91

557.90

e6/l

0.50

124

Disorders of refraction and accommodation

164

936

1.75

10.49

3.4

2.8

510.40

530.35

e6/l

0.23

131

753

Other general symptoms and signs

3.58

10.47

2.4

2.1

548.22

505.54

e6/l

0.21

Nasal polyp

435

2.13

10.45

2.3

2.8

588.51

486.93

e6/l

1.22

372

Acute laryngitis and tracheitis

339

2.28

10.45

3.4

2.5

539.05

539.62

e6/l

0.00

266

Other cataract

189

843

1.70

10.42

2.6

2.5

518.46

497.57

e6/l

0.24

157

712

COPD, hospital admissions 1, only main diagnosis

139

645

1.85

10.41

1.8

2.3

515.13

508.44

e6/l

0.06

118

547

Volume depletion

185

2.78

10.36

1.6

2.7

412.03

541.09

e6/l

1.23

156

Gout, unspecified

411

2.15

10.32

2.8

2.2

462.27

489.34

e6/l

0.22

355

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

158

900

1.76

10.32

2.1

2.7

554.89

519.64

e6/l

0.43

122

757

Atrial fibrillation and flutter

144

505

1.86

10.29

2.7

3.1

468.29

489.49

e6/l

0.20

121

434

Visual field defects

175

2.83

10.26

2.0

2.5

471.86

545.07

e6/l

0.44

147

Presence of other functional implants

226

968

1.62

10.26

1.9

2.1

533.95

519.85

e6/l

0.10

193

811

Congenital malformations of the respiratory system

3.81

10.23

2.4

3.5

646.13

502.18

e6/l

0.73

Conductive and sensorineural hearing loss

350

1608

1.47

10.20

2.3

2.6

533.74

528.78

e6/l

0.04

309

1345

Cystitis

397

1640

1.44

10.17

2.8

2.4

553.76

502.65

e6/l

0.91

321

1377

Congenital malformations of the respiratory system

3.88

10.14

2.4

3.7

646.13

506.09

e6/l

0.69

Tuberculosis, wide

123

3.20

10.13

1.7

2.1

698.09

496.97

e6/l

0.67

102

Acute bronchiolitis

274

2.37

10.11

3.0

3.3

553.33

534.54

e6/l

0.11

198

Irregular menses

233

1156

1.60

10.11

2.9

2.3

513.49

498.34

e6/l

0.26

197

962

Valvular heart disease excluding rheumatic fever

214

948

1.63

10.06

2.2

2.8

430.10

576.66

e6/l

2.35

174

807

Focal epilepsy, strict definition

113

586

1.94

9.98

2.4

2.8

493.23

506.51

e6/l

0.11

482

Cardiac arrhythmias

318

1385

1.50

9.97

2.5

2.8

483.76

524.31

e6/l

0.85

261

1160

Postmenopausal osteoporosis with pathological fracture

4.06

9.96

2.5

1.3

537.86

405.14

e6/l

0.45

Caries of enamel

447

2314

1.40

9.91

2.9

2.5

528.59

540.75

e6/l

0.17

356

1952

Other obstetric conditions, not elsewhere classified

183

684

1.71

9.91

1.9

2.5

562.30

508.15

e6/l

1.13

151

570

Malnutrition

4.34

9.90

3.4

2.6

748.83

460.02

e6/l

1.17

Abnormalities of gait and mobility

285

2.37

9.86

2.7

2.3

484.85

491.04

e6/l

0.03

240

Intestinal stricture

137

760

1.81

9.81

2.1

2.5

529.68

518.79

e6/l

0.09

121

627

Phlebitis and thrombophlebitis (not including DVT)

108

557

1.95

9.71

2.2

2.5

549.95

503.60

e6/l

0.37

475

Other congenital malformations

463

2.05

9.64

3.4

2.7

580.39

545.01

e6/l

0.28

365

Other epidermal thickening

3.52

9.64

2.0

2.1

698.56

472.56

e6/l

0.38

Glomerulonephritis

264

2.41

9.60

1.9

2.7

643.89

522.07

e6/l

0.41

216

Disorders of gallbladder, biliary tract and pancreas

452

2053

1.39

9.59

2.6

2.5

512.72

533.66

e6/l

0.31

373

1736

Gingivitis and periodontal diseases

504

1896

1.37

9.57

2.7

2.5

556.37

524.75

e6/l

0.44

412

1588

Sequelae with surgical and medical care as external cause

498

2.00

9.57

3.0

2.5

602.15

505.73

e6/l

1.00

420

Dermatographic urticaria

149

2.91

9.55

2.8

2.4

589.09

555.22

e6/l

0.15

123

Other diseases of hard tissues of teeth

251

826

1.58

9.53

2.4

2.3

530.89

562.25

e6/l

0.19

196

688

Hypertension, essential

370

1455

1.44

9.45

2.2

2.7

532.78

537.12

e6/l

0.04

313

1223

Other disorders of eyelid

175

1000

1.67

9.41

2.4

2.3

489.97

545.35

e6/l

0.57

153

834

Non-rheumatic valve diseases

207

925

1.62

9.41

2.2

2.7

433.90

575.72

e6/l

2.15

170

788

Presence of other devices

472

2.01

9.39

2.3

2.0

555.17

495.77

e6/l

0.26

398

Malignant neoplasm, without specification of site

8.11

9.35

3.2

1.6

514.67

459.05

e6/l

0.16

Pollen allergy

137

762

1.79

9.35

2.3

3.0

557.61

537.38

e6/l

0.19

113

604

Spirochaetal infections, other/unspecified

196

2.63

9.32

1.8

2.3

431.33

536.61

e6/l

0.95

165

Exposure to other specified factors

375

2439

1.41

9.31

2.5

2.6

519.25

522.77

e6/l

0.05

314

2023

Other embolism and thrombosis

280

2.34

9.31

2.4

455.98

500.87

e6/l

0.32

238

Herpesviral keratitis and keratoconjunctivitis

3.67

9.28

3.2

2.1

504.88

614.03

e6/l

0.40

Benign neoplasm: Colon, unspecified

106

552

1.93

9.28

2.3

2.5

499.21

500.64

e6/l

0.01

467

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

152

2.88

9.27

3.0

642.44

557.41

e6/l

0.51

115

Focal epilepsy

120

651

1.85

9.26

2.4

2.8

481.69

501.17

e6/l

0.17

538

Colonic or urogenital fistula

133

745

1.79

9.26

2.4

2.6

486.70

504.81

e6/l

0.15

108

624

Other peripheral vascular diseases

163

2.78

9.22

1.5

2.6

369.37

538.49

e6/l

1.44

143

Impetigo

147

2.90

9.20

2.7

2.9

608.00

563.83

e6/l

0.18

117

Benign neoplasm of other and ill-defined parts of digestive system

405

2.09

9.14

2.1

2.5

482.10

531.53

e6/l

0.50

345

Endocarditis

4.31

9.14

1.7

2.9

386.39

710.18

e6/l

1.00

Anogenital herpesviral [herpes simplex] infection

164

2.77

9.13

2.3

2.6

525.14

497.83

e6/l

0.20

133

Other diseases of anus and rectum

126

696

1.81

9.11

2.4

2.6

472.54

497.65

e6/l

0.26

102

582

Other and unspecified vasculitis limited to skin

4.85

9.09

2.6

1.7

459.00

498.88

e6/l

0.14

Varicella [chickenpox]

143

2.91

9.04

2.1

3.0

580.48

566.36

e6/l

0.04

119

Sensorineural hearing loss

320

1492

1.46

9.00

2.2

2.7

526.63

528.55

e6/l

0.02

284

1255

Viral hepatitis, IBD co-morbidity

3.85

8.95

2.3

2.6

830.25

535.33

e6/l

0.75

Diseases of inner ear

228

1430

1.55

8.95

2.2

2.5

510.35

533.52

e6/l

0.24

200

1194

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

248

2.39

8.93

1.8

2.0

447.78

440.17

e6/l

0.05

215

Pyogenic arthritis

123

3.03

8.84

1.6

2.7

519.73

508.01

e6/l

0.05

104

Hypertension

389

1559

1.41

8.84

2.2

2.8

526.73

540.30

e6/l

0.13

321

1302

Complications of internal orthopaedic prosthetic devices, implants and grafts

451

2.00

8.82

1.8

2.1

516.89

513.89

e6/l

0.02

377

Substance use, excluding alcohol

109

584

1.88

8.79

2.2

2.6

648.90

524.95

e6/l

1.71

487

Hypertensive diseases

390

1566

1.41

8.78

2.2

2.8

528.36

540.26

e6/l

0.11

322

1308

Gout, strict definition

365

2.12

8.77

2.6

2.3

512.02

519.97

e6/l

0.04

315

Vulvovaginal ulceration/inflammation in other diseases

151

2.81

8.75

2.7

2.4

548.26

491.29

e6/l

0.38

124

Dialysis

119

3.07

8.73

2.2

2.7

695.16

496.06

e6/l

0.38

Unspecified fall

242

1578

1.52

8.70

2.3

2.7

537.18

524.69

e6/l

0.16

211

1296

Microscopic polyangiitis

10.72

8.69

2.9

1.4

471.88

516.91

e6/l

0.11

Spinal stenosis

198

943

1.60

8.67

2.2

2.5

491.56

556.12

e6/l

0.70

175

802

Other ulcerative colitis

141

2.87

8.65

2.0

2.6

446.30

580.26

e6/l

0.85

123

Pyothorax

3.41

8.64

1.7

2.3

523.82

622.59

e6/l

0.31

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

175

671

1.66

8.64

2.0

2.5

565.03

508.74

e6/l

1.16

146

560

Focal epilepsy, mode (most common among epilepsy diagnosis)

103

545

1.90

8.63

2.4

2.8

499.66

501.58

e6/l

0.01

444

Persons with potential health hazards related to communicable diseases

220

1418

1.54

8.60

3.0

2.6

851.03

521.99

e6/l

1.13

170

1158

Cervical disc disorders

155

927

1.68

8.58

2.2

2.6

570.63

513.24

e6/l

0.76

132

788

Nummular dermatitis

164

2.71

8.57

3.5

2.7

497.45

483.86

e6/l

0.07

138

Spondylopathies (FG)

336

2.16

8.55

1.7

2.9

500.10

515.73

e6/l

0.10

282

Perforation of tympanic membrane

235

2.40

8.55

2.3

2.6

505.90

524.52

e6/l

0.11

198

Other CVD

389

2.07

8.53

1.8

2.3

454.99

527.16

e6/l

0.61

332

Golimumab

3.46

8.52

1.3

3.0

417.18

520.08

e6/l

0.56

Oesophageal varices

3.46

8.51

1.3

2.7

392.17

604.00

e6/l

0.87

Other diseases of the digestive system

134

772

1.74

8.50

2.3

2.6

485.31

517.82

e6/l

0.31

112

644

Tuberculosis

100

3.23

8.48

1.5

2.0

659.22

521.65

e6/l

0.32

Atopic dermatitis, strict definition

180

1098

1.61

8.48

2.4

2.8

526.84

539.22

e6/l

0.14

146

891

Nonpyogenic thrombosis of intracranial venous system

8.19

8.47

1.8

2.2

398.62

464.61

e6/l

0.28

Bell's palsy

267

2.30

8.47

3.2

2.5

553.12

533.60

e6/l

0.10

225

Varicella [chickenpox]

195

2.54

8.40

2.7

3.1

536.71

546.96

e6/l

0.03

160

Dependence on enabling machines and devices, not elsewhere classified

4.78

8.37

2.5

1.8

495.46

549.89

e6/l

0.14

Paralytic strabismus

155

2.74

8.35

2.9

2.3

462.54

554.26

e6/l

0.56

129

Migraine without aura and triptan purchases

504

1.92

8.27

2.4

2.7

472.14

542.56

e6/l

1.08

407

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

168

2.67

8.21

3.5

3.4

546.89

520.50

e6/l

0.14

127

Other arrhythmias

289

1502

1.45

8.20

2.3

2.7

453.84

550.52

e6/l

2.07

239

1262

Drug-induced polyneuropathy

6.60

8.16

7.2

3.3

513.20

522.31

e6/l

0.02

Reactive arthropathies

198

2.49

8.13

2.1

2.7

524.64

502.43

e6/l

0.13

166

Congenital malformations and deformations of the musculoskeletal system

395

2.03

8.13

2.1

2.9

623.09

545.10

e6/l

0.72

306

Haemorrhoids and perianal venous thrombosis

127

729

1.74

8.12

2.0

2.5

488.18

494.98

e6/l

0.06

103

612

GI-bleeding

131

761

1.73

8.09

2.4

2.6

491.49

513.17

e6/l

0.18

109

632

Other disorders of conjunctiva

311

2.17

8.09

2.1

2.5

423.40

524.17

e6/l

1.07

264

Fracture of lumbar spine and pelvis

458

1.95

8.09

2.1

2.4

504.23

514.61

e6/l

0.06

385

Hypopituitarism

248

2.32

8.06

2.8

3.1

532.92

546.58

e6/l

0.07

206

Chronic apical periodontitis

519

2235

1.32

8.02

2.5

2.4

530.10

531.44

e6/l

0.02

434

1866

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

109

584

1.82

7.97

2.4

2.9

470.17

549.69

e6/l

0.85

462

Motor disorders, excluding more controls

3.23

7.91

3.2

2.8

657.79

549.66

e6/l

0.38

Excessive, frequent and irregular menstruation

186

635

1.61

7.91

2.8

2.1

489.96

496.60

e6/l

0.10

163

523

Disorders of vestibular function (Vertigo)

190

1201

1.56

7.86

2.2

2.5

529.43

544.49

e6/l

0.12

165

1005

Malignant neoplasm of bone and articular cartilage

9.74

7.86

4.7

2.1

700.30

477.64

e6/l

—

Delayed milestone in childhood

176

2.56

7.85

3.4

3.9

556.54

555.02

e6/l

0.01

126

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

121

2.91

7.84

2.6

1.5

502.12

440.98

e6/l

0.37

107

Exposure to unspecified factor

480

2607

1.33

7.83

2.2

2.6

541.14

533.53

e6/l

0.11

385

2184

Strabismus

151

918

1.65

7.83

2.9

2.8

445.80

533.87

e6/l

2.28

128

741

Malignant neoplasm of bladder, including Hilmo

115

2.95

7.81

2.3

1.5

647.90

427.66

e6/l

1.71

104

Other female pelvic inflammatory diseases

396

2.01

7.80

2.3

2.5

575.09

487.35

e6/l

0.90

325

Polycystic ovarian syndrome, consortium definition

317

1320

1.43

7.78

2.7

2.3

514.93

523.96

e6/l

0.09

271

1097

Allergic contact dermatitis

343

2.08

7.76

1.5

2.7

527.91

493.51

e6/l

0.30

289

Other local infections of skin and subcutaneous tissue

259

2.26

7.72

4.0

2.8

513.80

525.81

e6/l

0.05

215

Thyroiditis, ILD-related definition

240

2.31

7.72

2.1

2.2

398.87

590.01

e6/l

2.25

192

Non-selective monoamine reuptake inhibitors

159

949

1.62

7.69

1.9

2.4

574.23

554.28

e6/l

0.13

131

817

Unspecified haematuria

171

889

1.60

7.67

2.6

2.5

522.70

514.47

e6/l

0.05

141

756

Pain and other conditions associated with female genital organs and menstrual cycle

104

526

1.82

7.66

2.0

2.1

525.26

505.45

e6/l

0.21

431

Respiratory tuberculosis

3.28

7.66

1.5

2.1

754.43

560.75

e6/l

0.42

Respiratory tuberculosis, confirmed and not-confirmed

3.28

7.66

1.5

2.1

754.43

560.75

e6/l

0.42

Malignant neoplasm of bronchus and lung

166

2.46

7.66

2.2

1.6

438.33

422.44

e6/l

0.11

144

Polyarthrosis

350

2.02

7.63

2.3

2.5

461.49

516.44

e6/l

0.48

290

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

295

2.16

7.60

2.8

3.1

645.00

540.65

e6/l

1.02

229

Bacterial, viral and other infectious agents

249

2.27

7.55

2.4

3.1

520.46

564.88

e6/l

0.28

217

Injuries to the abdomen, lower back, lumbar spine and pelvis

175

1105

1.57

7.49

2.3

2.6

728.95

518.68

e6/l

0.49

147

917

Dermatophytosis

302

2.13

7.45

2.5

509.44

530.42

e6/l

0.12

251

Other specified/unspecified bacterial intestinal infections

136

2.74

7.44

2.2

2.4

576.78

534.76

e6/l

0.12

116

Seborrhoeic keratosis

459

1.90

7.42

2.5

544.24

490.41

e6/l

0.22

391

Other follicular disorders

189

2.46

7.41

2.4

2.9

690.02

540.59

e6/l

1.03

160

Specific development disorders of scholastic skills

205

2.39

7.38

5.8

2.6

568.10

525.91

e6/l

0.23

156

Intestinal adhesions without obstruction

148

2.65

7.38

2.2

488.58

455.68

e6/l

0.15

124

Diseases of external ear

163

1029

1.59

7.35

2.3

2.7

558.42

516.38

e6/l

0.58

136

852

Special screening examination for other diseases and disorders

154

2.61

7.33

2.5

2.0

520.38

545.98

e6/l

0.17

126

Other and unspecified nerve root and plexus disorders, also in other diseases

519

1.84

7.29

2.4

2.7

564.73

521.64

e6/l

0.34

439

Allergic purpura

3.53

7.29

1.9

2.4

372.21

531.39

e6/l

0.88

Other and unspecified local infections of skin and subcutaneous tissue

247

2.24

7.25

4.1

2.7

518.13

524.16

e6/l

0.02

205

Spondylolisthesis/Spondylolysis

421

1.93

7.24

1.8

2.8

454.60

500.58

e6/l

0.33

362

Paracetamol or NSAID medication

244

1.93

7.14

3.5

3.3

615.52

492.52

e6/l

0.56

200

Rosacea

288

2.13

7.11

2.4

456.06

502.87

e6/l

0.40

240

Scleritis and episcleritis

140

2.67

7.06

2.4

2.5

581.39

595.10

e6/l

0.04

114

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

109

609

1.75

7.01

2.4

2.9

470.22

544.38

e6/l

0.78

479

Injuries to the ankle and foot

345

2253

1.36

7.01

2.4

2.6

506.90

521.88

e6/l

0.26

286

1871

Conduction disorders

120

573

1.70

6.90

2.1

2.7

395.31

541.01

e6/l

2.67

104

484

Diseases of peritoneum

215

2.29

6.84

2.2

2.3

675.62

506.71

e6/l

0.44

180

Erythema nodosum

3.82

6.82

2.1

1.9

447.73

497.43

e6/l

0.19

Dystonia

120

2.78

6.81

3.1

2.3

457.19

528.16

e6/l

0.35

100

Bacterial, viral and other infectious agents

229

2.24

6.76

2.5

3.1

516.56

564.43

e6/l

0.29

201

Unspecified chronic bronchitis

3.66

6.75

1.9

2.0

478.07

557.86

e6/l

0.25

Sleep disorders (combined)

523

2127

1.29

6.75

2.1

2.6

551.50

526.18

e6/l

0.36

439

1777

Trigeminal neuralgia

104

2.91

6.74

2.9

2.3

454.00

576.89

e6/l

0.55

Other bursopathies

288

2.09

6.72

2.2

2.8

417.06

513.45

e6/l

1.21

248

Hypotension

309

2.05

6.66

1.7

2.2

494.57

508.04

e6/l

0.07

264

Otitis externa, unspecified

303

2.06

6.64

2.7

2.9

563.65

528.45

e6/l

0.26

246

Other external causes of accidental injury

410

1541

1.33

6.63

2.5

2.7

513.42

527.98

e6/l

0.25

339

1280

Sleep apnoea

408

1995

1.33

6.61

2.1

2.6

558.09

527.12

e6/l

0.38

353

1661

STROKE

243

1148

1.44

6.59

2.3

2.9

518.71

539.67

e6/l

0.25

204

971

Crossbite

305

2.02

6.58

3.7

3.2

539.40

542.69

e6/l

0.02

239

Other disorders starting during childhood or adolecense, excluding more controls

197

2.31

6.58

4.4

2.7

561.87

521.55

e6/l

0.23

143

Lichen simplex chronicus and prurigo

111

2.81

6.58

2.0

2.2

592.48

470.28

e6/l

0.59

Heart failure and coronary heart disease

159

720

1.57

6.49

2.0

2.4

378.30

521.01

e6/l

4.65

136

603

Hard cardiovascular diseases

376

1675

1.34

6.48

2.1

2.8

512.96

525.07

e6/l

0.14

318

1399

External causes of morbidity and mortality

324

1179

1.38

6.46

2.5

523.85

517.88

e6/l

0.08

271

968

Chondropathies

417

1.88

6.46

3.2

2.5

554.54

531.96

e6/l

0.15

344

Disorders of muscles

240

2.18

6.46

2.0

2.7

494.61

519.01

e6/l

0.15

202

Cardiomyopathy

375

1.93

6.45

2.2

2.7

475.72

532.02

e6/l

0.29

311

Nocardiosis

+∞

6.43

4.5

0.0

723.50

—

e6/l

—

Congenital malformations and deformations of the musculoskeletal system

459

1.83

6.40

2.1

2.7

607.31

545.90

e6/l

0.57

357

Seborrhoeic dermatitis

203

2.28

6.36

2.3

2.6

753.38

498.21

e6/l

0.72

170

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

324

1.99

6.35

2.0

446.36

436.14

e6/l

0.07

278

Other hammer toe(s) (acquired)

296

2.00

6.31

1.9

2.4

428.80

525.33

e6/l

1.03

245

Other diseases of liver

471

1.81

6.30

2.2

2.7

545.36

503.69

e6/l

0.29

391

Other salmonella infections

3.48

6.30

2.1

394.88

519.42

e6/l

0.75

Congenital malformations of trachea and bronchus

5.22

6.27

2.6

3.5

641.62

532.74

e6/l

0.35

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS